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Abstract
Secretory vesicles in endocrine cells store hormones such as growth hormone (GH) and insulin before their release into the
bloodstream. The molecular mechanisms governing budding of immature secretory vesicles from the trans-Golgi network
(TGN) and their subsequent maturation remain unclear. Here, we identify the lipid binding BAR (Bin/amphiphysin/Rvs)
domain protein PICK1 (protein interacting with C kinase 1) as a key component early in the biogenesis of secretory vesicles
in GH-producing cells. Both PICK1-deficient Drosophila and mice displayed somatic growth retardation. Growth retardation
was rescued in flies by reintroducing PICK1 in neurosecretory cells producing somatotropic peptides. PICK1-deficient mice
were characterized by decreased body weight and length, increased fat accumulation, impaired GH secretion, and
decreased storage of GH in the pituitary. Decreased GH storage was supported by electron microscopy showing prominent
reduction in secretory vesicle number. Evidence was also obtained for impaired insulin secretion associated with decreased
glucose tolerance. PICK1 localized in cells to immature secretory vesicles, and the PICK1 BAR domain was shown by live
imaging to associate with vesicles budding from the TGN and to possess membrane-sculpting properties in vitro. In mouse
pituitary, PICK1 co-localized with the BAR domain protein ICA69, and PICK1 deficiency abolished ICA69 protein expression.
In the Drosophila brain, PICK1 and ICA69 co-immunoprecipitated and showed mutually dependent expression. Finally, both
in a Drosophila model of type 2 diabetes and in high-fat-diet-induced obese mice, we observed up-regulation of PICK1
mRNA expression. Our findings suggest that PICK1, together with ICA69, is critical during budding of immature secretory
vesicles from the TGN and thus for vesicular storage of GH and possibly other hormones. The data link two BAR domain
proteins to membrane remodeling processes in the secretory pathway of peptidergic endocrine cells and support an
important role of PICK1/ICA69 in maintenance of metabolic homeostasis.
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Introduction
The regulated secretory pathway is a hallmark of endocrine,
exocrine, and neuronal cells and involves formation of secretory
vesicles to enable storage and regulated secretion of cargo
molecules [1,2]. Peptide hormones and neuropeptides are
synthesized as larger precursors in the endoplasmic reticulum
and targeted to the Golgi apparatus. At the trans-Golgi network,
the precursors are packaged into immature secretory vesicles that
bud from the TGN. During maturation of the immature vesicles,
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the precursors are processed to active hormones, which are
secreted in a regulated manner by fusion of the secretory vesicles
with the plasma membrane. Although several steps in the
regulated secretory pathway have been characterized, the mech-
anism underlying biogenesis of the secretory vesicles is still poorly
understood [1,2]. A key question is, which molecular components
that are responsible for the membrane remodeling and reshaping
that is required for budding of vesicles from the TGN and the
subsequent maturation of these vesicles. Previous studies indicated
that generation of the necessary membrane curvature at the TGN
depends on lipids such as diacylglycerol, phosphatidic acid, and
cholesterol [1,3–5]. In addition, it has been suggested that
hormone precursors aggregate together with chromogranins in
membrane rafts of the TGN, thereby providing a driving force for
vesicle budding [1,6,7]. The general importance of chromogranins
has been substantiated both by depletion experiments in endocrine
cells and overexpression experiments in non-endocrine fibroblast-
like cells leading to ‘‘de novo’’ formation of dense core-like
granules containing chromogranin [1,6,7]. However, the exact
molecular components involved in secretory vesicle formation
remain unknown.
BAR (Bin/amphiphysin/Rvs) domains are crescent-shaped
dimeric a-helical modules that are essential in dynamic
remodeling of lipid membranes by means of their unique
capacity to both sense and impose membrane curvature [8–11].
BAR-domain proteins have been implicated in a variety of
cellular functions including clathrin-mediated endocytosis where
at least four different BAR-domain proteins, including FCHO1/
2, endophilin, amphiphysin, and SNX9, are known to be
involved in the vesicle budding and fission process [12,13].
Analogous to the plasma membrane, the TGN is a ‘‘hotspot’’ for
membrane remodeling and vesicle formation; however, the
processes occurring at the TGN have not been characterized in
similar details.
Protein interacting with C kinase 1 (PICK1) is a BAR domain
protein with homology to the BAR domain proteins ICA69 (islet
cell autoantigen 69) and arfaptin 1/2 [14–18]. The protein is
widely distributed in the body with highest known expression in
the brain, pancreas, and testis [19]. In the brain, PICK1 is found
in many different regions [19] and known for regulating trafficking
and phosphorylation of neurotransmitter receptors, such as the a-
amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)-
type ionotropic glutamate receptor, to which PICK1 binds via
an N-terminal PSD-95/Discs-large/ZO-1 homology (PDZ) do-
main [14–17]. Recently, we unexpectedly discovered that in the
Drosophila brain, PICK1 is almost exclusively expressed in
peptidergic neurons [20]. Peptide hormones released from these
neurosecretory cells are critical for growth and metabolism, but
the functional significance of PICK1 expression in these cells is
unknown. Of further interest, previous data have suggested that
PICK1 exists in part in a heterodimeric complex with the
homologous BAR domain protein, ICA69 [19]. ICA69 was
originally identified as diabetes-associated autoantigen in islet cells
of the pancreas and is functionally poorly characterized [21]. It
contains an N-terminal BAR domain with homology to the
PICK1 BAR domain and a rather long C-terminal domain of
unknown structure and function [19]. ICA69 has been suggested
to regulate neurosecretory processes [22] and to prevent synaptic
targeting/localization of PICK1 [19].
Here, we show that PICK1 is not only expressed in
neurosecretory cells of Drosophila but also in hormone-producing
cells of the mouse pituitary. Phenotypic characterization of mutant
PICK1-deficient flies and mice reveal that both are characterized
by marked somatic growth retardation. In the flies, this can be
rescued by reintroducing PICK1 selectively in peptidergic
neurosecretory cells. In the PICK1-deficient mice, we find clear
signs of GH deficiency that can be attributed to reduced formation
of GH-containing dense core secretory vesicles in the pituitary. We
find moreover evidence for decreased levels of prolactin in the
pituitary as well as for impaired insulin secretion from the
pancreas. Our further analyses indicate a transient localization of
PICK1 to early secretory vesicles budding from the TGN, and in
vitro we find that the PICK1 BAR-domain can actively sculpt lipid
membranes. We also obtain evidence that PICK1 exerts its action
in endocrine cells in a heterodimeric complex with ICA69. A more
general role of the PICK1/ICA69 complex in secretory vesicle
formation is supported by the observation that PICK1 and ICA69
promote vesicular chromogranin localization in non-endocrine
COS7 cells. Furthermore, PICK1 mRNA expression is up-
regulated in both a Drosophila model of type 2 diabetes (T2D)
and in high-fat-diet-induced obese mice. Summarized, our results
suggest a hitherto unknown key role of PICK1 and ICA69 in
secretory vesicle formation at the TGN and indicate a putative
role of PICK1 during metabolic disease.
Results
Growth Retardation in PICK1-Null Drosophila
By immunostaining we observed an unanticipated PICK1 signal
in neurosecretory cells of Drosophila melanogaster [20]. Because some
of these cells secrete peptides governing growth and metabolism,
we compared the body weight of Drosophila PICK1-null mutants
with wild-type (WT) flies. Adult flies, which were homozygous or
transheterozygous for two PICK1-null alleles, PICK11 and PICK12
[20], exhibited significant weight loss compared to controls
(Figure 1A). The weight loss was fully rescued in both females
and males when expressing PICK1 under control of the DIMM
promoter, using the c929-GAL4 driver line (Figure 1A) [20,23].
This is in agreement with DIMM encoding a transcription factor
important for differentiation of peptidergic cells and with the
observation that the expression of PICK1 and DIMM largely
overlaps [20,23]. In Drosophila, somatic growth and energy
Author Summary
Regulated secretion of peptide hormones, such as growth
hormone (GH) and insulin, represents a fundamental
process in controlling physiological homeostasis. In endo-
crine cells, hormone-containing vesicles bud from the
Golgi apparatus to enable storage and regulated release
into the blood stream. Here we show that two proteins
with a lipid membrane-shaping BAR domain, PICK1 and
ICA69, work together in the pituitary gland and the
pancreas to facilitate the budding of early secretory vesicle
from the Golgi apparatus. The physiological significance of
our findings was borne out by showing that mice and
Drosophila flies lacking the PICK1 encoding gene have
marked growth retardation. PICK1-deficient mice showed
increased fat accumulation, reduced body weight and
length, as well as reduced glucose clearance from the
blood stream. Consistent with these findings, we observed
a severe reduction in GH storage in the pituitary and
impaired secretion of both insulin and GH in response to
physiological stimuli. Finally, we found that PICK1 expres-
sion levels were raised in a fly model of type 2 diabetes
and in high-fat-diet-induced obese mice. These results
indicate that alteration of PICK1 expression might play a
role in pathophysiological processes of metabolic diseases
and/or in a protective compensatory mechanism.
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homeostasis is influenced by a family of insulin-like peptides
(dILPs) that function equivalently to growth hormone (GH) and
insulin in mammals [24]. When driving PICK1 expression under
the dILP2 promoter, normal growth was rescued in females with a
nonsignificant trend in males (Figure 1A). Together, the results
suggest that to ensure proper growth regulation in Drosophila,
PICK1 must be expressed in peptidergic cells, of which cells
secreting dILPs play a major role.
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Figure 1. Involvement of PICK1 in somatic growth and body composition. (A) Body weight of female (black) and male (grey) control
Drosophila flies, Drosophila PICK1-null mutants, and rescued mutants (dILP and c929). Rescued mutants included PICK11/PICK2 transheterozygotes
with expression of HA-tagged UAS-PICK1 transgene either under the dILP2 promotor to drive expression in peptidergic cells secreting Drosophila
insulin-like peptides (dILPs) [24], or under the generally peptidergic DIMM promoter (c929) [20,23]. Data are means 6 SE of at least 15 data points,
where each point represents the average from weighing 3–8 flies. Genotypes: ‘‘c929 rescue,’’ c929-GAL4 PICK1/PICK2 UAS-PICK1-HA; ‘‘dILP2 rescue,’’
PICK1/PICK2 UAS-PICK-HA; dILP2/+. ***p,0.0001 (compared to Control); ###p,0.0001 (compared to PICK1/PICK2). (B) PICK1-deficient mice display
reduced body weight at both age ,11.5 wk and age 36.5 wk. Data are means 6 SE (n$7). **p,0.01, ***p,0.001, compared to WT mice. #p,0.05,
compared to PICK1-deficient mice. (C) PICK1-deficient mice display reduced body length between nose and tail root. Measurements were performed
in anesthetized mice at 10–12 wk of age. Data are means6 SE (n= 11). *p,0.01, compared to WT mice. (D and E) PICK1-deficient mice display altered
body composition. Fat mass and lean mass were determined in unanesthetized mice at 15–17 wk of age by quantitative magnetic resonance
imaging. Data are presented as percent of total body weight (means 6 SE, n=7–10). *p,0.05, compared to WT mice.
doi:10.1371/journal.pbio.1001542.g001
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Somatic Growth Retardation and GH Deficiency in PICK1-
Deficient Mice
To probe the importance of PICK1 for neuroendocrine
function in mammals, we studied mice with targeted disruption
of the PICK1 gene (PICK1-deficient mice) [14]. In accordance
with our Drosophila findings, PICK1-deficient mice displayed
significantly lower body weight and length compared to WT
littermates (Figure 1B–C). To evaluate the body composition of
the mice, we performed MRI scans, which revealed significantly
higher fat percentage in PICK1-deficient animals (Figure 1D). In
contrast, the percentage of lean body mass was unchanged
(Figure 1E). However, as expected from the lower body weight and
length, the absolute lean mass in grams was significantly decreased
in PICK1-deficient mice (Figure S1A–B).
The PICK1-deficient mice did not differ significantly from WT
littermates in their food and water intake, energy expenditure, or
preference for fuel consumption, as determined in calorimetric
cages over 72 h (Figure S1C–H). This suggested that the growth
impairment and change in body composition were likely the result
of a defect in the function of anabolic hormones. Surmising that
GH might be a prime candidate, we measured liver weight, IGF-1
(insulin-like growth factor-1) levels, and femur length, all well-
established markers of the average daily GH secretion [25]. Note
that because GH is secreted in a pulsatile manner, direct
measurements of plasma GH do not reliably assess total GH
secretion. Indeed, the weight of the liver, the femur length, and
both the IGF-1 plasma level and liver mRNA level were
significantly decreased in PICK1-deficient mice (Figure 2A–D).
To assess the ability of the mice to secrete GH in response to a
physiologically relevant stimulus, we measured the plasma level of
GH 5 min after treatment with ghrelin [26]. In PICK1-deficient
mice, the plasma levels of GH were significantly lower after ghrelin
than in littermate controls (Figure 2E). This decrease in secretion
might be the result of impaired hormone storage since the total
content of GH in the pituitary was markedly decreased in PICK1-
deficient mice, as measured by ELISA (Figure 2F). The content of
prolactin was also significantly decreased, whereas a tendency
toward reduction was seen for ACTH and TSH (Figure S2). The
impaired storage of GH was not caused by decreased transcrip-
tional activity, because quantitative PCR revealed similar GH
mRNA levels in WT and PICK1-deficient mice (Figure 2G). In
contrast, the GH receptor mRNA levels were up-regulated
(Figure 2G), possibly reflecting a mechanism to compensate for
the decreased GH level.
Impaired Glucose Tolerance and Reduced Insulin
Secretion in PICK1-Deficient Mice
To characterize further the influence of PICK1 on metabolism,
we performed oral glucose tolerance tests (OGTTs). In response to
the glucose load, we observed a significant delay in plasma glucose
clearance (Figure 3A) and, consistent with this, also a decrease in
insulin secretion in PICK1-deficient mice (Figure 3B). These
findings indicate that not only GH secretion but possibly also
insulin secretion is impaired in the absence of PICK1. The
impaired glucose tolerance was not due to the insulin resistance
commonly observed in obese animal models of T2D. On the
contrary, an insulin tolerance test (ITT) revealed increased insulin
sensitivity in the PICK1-deficient mice as illustrated by a
significant reduction in AUC (area under curve) (Figure 3C). In
accordance with the increased insulin sensitivity, we observed
increased insulin receptor expression in the liver (Figure 3D).
Interestingly, increased insulin sensitivity has previously been
observed in animal models characterized by impaired GH action
[27]. Finally, we found decreased plasma triglyceride levels
(Figure 3E), as described in other rodent models of GH deficiency
[28]. Together, our data suggest that the metabolic phenotype of
PICK1-deficient mice is characterized to a large degree by a GH
deficit. In addition, the results suggest an impairment of insulin
secretion in agreement with work by Xia and colleagues [29].
Rescue of the Metabolic Phenotype Observed in PICK1-
Deficient Mice by Exogenous Administration of GH
To elucidate better the contribution of the GH deficiency to the
phenotype observed in the PICK1-deficient mice, we adminis-
trated GH once daily to adult (12–16 wk old) mice for 3 wk.
Before the treatment was initiated, we measured body weight and
body composition of the mice as well as performed oral glucose
tolerance and ITTs. Importantly, the data described in Figures 2
and 3 were confirmed in this cohort of mice (unpublished data).
During the treatment period, the body composition was measured
every week. The PICK1-deficient mice gradually approached the
lean body mass of the littermate WT control mice and were
indistinguishable from these already after 2 wk of treatment
(Figure 4A), consistent with a rescue of the phenotype by GH
administration. We also observed a rescue of the strongly
decreased IGF-1 mRNA levels in the liver of the PICK1-deficient
mice—that is, the IGF-1 mRNA level in the liver after GH
treatment was not significantly different from WT littermate
control mice (Figure 4B). The GH treatment, however, did not
affect glucose tolerance (Figure 4C). In contrast, the increased
insulin sensitivity was rescued by GH administration, as no
difference between PICK1-deficient mice treated with GH and
wild-type littermate controls was observed (Figure 3C versus
Figure 4D). In summary, the data substantiate the contribution of
the GH deficiency to the metabolic phenotype of PICK1-deficent
mice and emphasize the conceivable additional contribution from
impaired insulin secretion.
PICK1 Is Expressed in the Pituitary and PICK1-Deficiency
Leads to a Reduced Pool of Dense Core Secretory
Vesicles
To investigate the cellular basis for the metabolic phenotype of
PICK1-deficient mice, we performed an immunohistochemical
analysis of pituitaries from WT and PICK1-deficient mice. Intense
PICK1 immunoreactivity was observed in a large fraction of WT
pituitary cells (Figure 5A). Around half of the PICK1-positive cells
were also positive for GH, while essentially all GH-positive cells
showed concomitant PICK1 staining (Figure 5A). In individual
WT cells, the GH staining formed a dense, often arc-shaped,
pattern. Interestingly, in pituitaries from PICK1-deficient mice,
the GH staining appeared less intense and less well organized, with
no or only very few cells showing the WT pattern (Figure 5A).
Electron microscopy confirmed the difference in intracellular
structure of the GH-producing cells (identified by their character-
istic architecture [30]). In the PICK1-deficient GH cells, we
observed a reduction in the number of secretory dense core
vesicles (DCVs) compared to WT cells (Figure 5B–C). The
remaining vesicles were located at the cellular periphery
(Figure 5B) with a possible slight decrease in the average size of
the vesicles (Figure 5D). These observations further support that
the GH pool is reduced in PICK1-deficient mice.
To assess whether PICK1 also was expressed in other endocrine
cells of the pituitary, we performed immunostainings for prolactin
and ACTH. A large proportion of cells with ACTH immunore-
activity were positive for PICK1 and, like GH in GH-producing
cells, the ACTH immunosignal formed a circular pattern around
PICK1 in Biogenesis of Secretory Vesicles
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the nuclei (Figure S3). For prolactin-positive cells, we also observed
PICK1 immunosignal in a fraction of the cells, but we also
observed cells that were positive for prolactin but showed no
detectable PICK1 immunoreactivity (Figure S3). Thus, PICK1
expression is not restricted to GH-producing cells of the pituitary,
coherent with a putative role of PICK1 in secretion of other
pituitary hormones.
PICK1 Is Expressed in GH-Producing GH1 Cells and Is
Critical for GH Storage
To exclude that the reduced GH pool was due to a defect in
hypothalamic regulation, we studied GH1 cells, a GH-secreting
cell line [31]. Immunostainings of these cells revealed a strong
PICK1 signal (Figure 6A). To test if PICK1 is critical for the
GH level in GH1 cells, we used shRNA to knock down PICK1
expression. Knockdown of PICK1 significantly decreased GH
immunoreactivity, and thereby conceivably GH storage in
shRNA transfected cells, which were identified by their obligate
coexpression of EmGFP (Figure 6A–C). A control shRNA
construct neither decreased PICK1 nor GH immunoreactivity
(Figure 6B–C). Note that because only ,5% of the GH1 cells
were transfected with the shRNA constructs, it was not possible
to assess PICK1 knockdown by, for example, western blotting or
the effect on GH levels by ELISA. We should also note that
PICK1 deficiency is unlikely to cause enhanced degradation of
GH via the lysosomal pathway. Knockdown of PICK1 did not
enhance co-localization of GH with lysosomal markers such as
lysotracker and LAMP1, and overnight incubation of PICK1-
depleted GH1 cells with an inhibitor of lysosomal degradation
(leupeptin) did not rescue the GH immunosignal (unpublished
data).
To test if PICK1 deficiency in other isolated endocrine cell lines
depletes the secreted hormones, we analyzed the effect of PICK1
knockdown in the ACTH-producing AtT-20/D16v-F2 cell line
(ATT20) [32]. In accordance with our findings for GH in GH1
cells, we observed a strong PICK1 immunosignal, and shRNA-
mediated knockdown of PICK1 expression significantly reduced
the ACTH immunosignal in these cells (Figure S4).
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The reduced number of GH-containing DCVs in the
pituitary of PICK1-deficient mice, together with reduced GH
immunoreactivity in GH1 cells upon PICK1 knockdown,
suggest that PICK1 might be directly involved in the biogenesis
of GH-containing secretory vesicles. However, although we
observed some colocalization of PICK1 with GH punctae in the
GH1 cells (Figure 6A, inset ii, and Figure 6D), the PICK1
staining did only in part localize to the GH-positive vesicles and
was also seen in juxtanuclear clusters (Figure 6A). The
transferrin receptor, a marker of the early endocytic and
recycling pathway, did not co-localize with these juxtanuclear
PICK1 clusters, nor did the lysosomal marker LAMP1 (Figure
S5A–B). To quantify the co-localization we applied Van
Steensel’s cross-correlation analysis, in which the Pearson
cross-correlation is calculated as the signal from one channel
(i.e., blue for PICK1) was shifted relative to the signal from the
other channel (i.e., green for GH) in the x-direction pixel by
pixel. In the Van Steensel’s cross-correlation function, the
Pearson cross-correlation is then plotted against Dx [33].
Consistent with partial but specific co-localization between
PICK1 and GH, the cross-correlation function peaked at Dx = 0
with a value of <0.13 (Figure 6D). In contrast, we observed
essentially no cross-correlation with transferrin or LAMP1
(Figure S5D).
We then tested whether PICK1 colocalized with markers for the
entire Golgi (58K), the cis-Golgi (GM130, giantin), or the trans-
Golgi network (TGN38). Although we did observe some overlap,
the PICK1 staining generally displayed a more punctate pattern
than the Golgi markers. Moreover, the PICK1 signal was
preferentially enclosed by, or closely associated with, the Golgi
markers rather than directly co-localizing with them (Figures 6E
and S6A–B). Cross-correlation analysis confirmed these observa-
tions and revealed the highest maximum cross-correlation value
(,0.4) for TGN38 compared to ,0.2 for giantin that also
displayed a strongly broadened peak, consistent with adjacent
localization of PICK1 and giantin with little true overlap
(Figure 6F). A similar pattern of immunoreactivity was seen in
Drosophila brains in which PICK1 immunoreactivity associated
closely both with the trans-Golgi marker golgin-97 (Figure S6C)
and with cis-Golgi markers [20] without truly overlapping.
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Figure 3. Dysregulation of glucose homeostasis in PICK1-deficient mice. (A) Impaired glucose tolerance in PICK1-deficient mice. OGTT was
done in 10–13-wk-old WT (+/+) and PICK1-deficient mice (2/2) after overnight fast. White circles, PICK1 +/+; black circles, PICK1 2/2. The inset
shows area under curve (AUC). Data are means 6 SE (n=9). **p,0.01. (B) Mice deficient in PICK1 display decreased insulin secretion during OGTT.
White bars, PICK1 +/+: black bars, PICK1 2/2. Data are means 6 SE. *p,0.05. (C) Mice deficient in PICK1 (27–29 wk) display preserved or even
improved insulin sensitivity in the ITT. White circles, PICK1 +/+; black circles, PICK1 2/2. Data are means 6 SE (n= 9–11). AUC was significantly lower
for the PICK1-deficient mice compared to WT mice. *p,0.05. (D) The protein expression level of the insulin receptor as determined by quantification
of Western blots on liver samples from 35–38-wk-old mice after overnight fasting was significantly increased in PICK1-deficient mice (2/2) compared
to WT (+/+) mice (means 6 SE, *p=0.024). Western blots with insulin receptor and actin immunoreactivity of two representative samples out of 13
PICK2/2 and 10 PICK+/+ samples are shown below. (E) The plasma levels of triglycerides (TG) after overnight fasting were significantly decreased in
PICK1-deficient mice (2/2) compared to WT (+/+) mice (154615 versus 10369, n=10–13, **p= 0.0056).
doi:10.1371/journal.pbio.1001542.g003
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Moreover, we observed that PICK1 immunoreactivity surrounded
zones of high dILP2 immunoreactivity in dILP-producing cells,
with only partial overlap between the two signals (Figure S6D).
PICK1 Is Localized to Immature Vesicles Exiting the TGN
and PICK1 Tubulates Lipid Vesicles in Vitro
The strong PICK1 immunosignal adjacent to the Golgi led us to
investigate the co-localization with markers of vesicles that either enter
or exit the Golgi. We observed a noticeable co-localization with
ERGIC53, a marker of the ER-Golgi intermediate compartment
(ERGIC) (Figure S5C–D). A more striking co-localization was
observed for syntaxin 6, a marker of immature secretory vesicles
leaving the TGN (Figure 6E) [34]. When focusing on the punctate
staining, it was possible to identify many punctae positive for both
PICK1 and syntaxin 6 (Figure 6G). Furthermore, by staining
simultaneously for PICK1, GH, and syntaxin 6, we were able to
identify punctae and thus presumably early, immature vesicles positive
for PICK1, syntaxin 6, and GH (Figure S6E–F). Cross-correlation
analysis of the syntaxin 6/PICK1 staining substantiated the strong co-
localization; that is, the cross-correlation function peaked essentially at
DX=0 with a maximum value of 0.55. Importantly, this suggests
stronger co-localization between PICK1 and syntaxin 6 than between
PICK1 and the Golgi markers (Figure 6F).
We next tested how PICK1 localization was affected by
brefeldin A (BFA), an Arf1 inhibitor, which acutely arrests
vesiculation at the Golgi [35]. Interestingly, a brief (5 min)
treatment with BFA enhanced the apparent co-localization of
PICK1 with TGN38 relative to syntaxin 6 (Figure 7A). Cross-
correlation analysis of these data showed that in the absence of
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Figure 4. Rescue of the phenotype of PICK1-deficient mice by GH administration. (A) Lean body mass was evaluated by MRI scanning
before GH administration and subsequently once every week both in PICK1-deficient mice (black squares) and in saline-treated WT littermates (white
circles). Before treatment the difference between the two groups was highly significant (**p=0.0027), after a week the difference decreased but was
still significant (*p= 0.050), and after 2 and 3 wk no significant difference were observed. (B) IGF-1 mRNA level in the liver as determined by RT-PCR
was significantly lower in PICK1-deficient mice compared to untreated mice (*p= 0.0045), however this difference was not observed after GH-
treatment for 3 wk. (C) OGTT and ITT on GH-treated PICK1-deficient mice (black circles) and the saline-treated WT littermate controls (white circles).
Significant difference was observed in the OGTT, whereas no difference was observed in ITT. Data are expressed as mean 6 SE and analyzed by two-
way ANOVA in (A) and Student’s t test in (B–D) (n= 4–8 in all the experiments). All experiments have been reproduced in another cohort of mice
(n=3–4), where the age of the mice was 4 wk higher.
doi:10.1371/journal.pbio.1001542.g004
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BFA the cross-correlation between the PICK1 and syntaxin 6
immunosignal was clearly higher than that between PICK1 and
TGN38, whereas the cross-correlation signal was essentially
identical after BFA treatment (Figure 7B).
Note that after BFA treatment the cross-correlation maximum
was lower for both TGN38 and syntaxin 6 (compare to Figure 6F).
This is most likely a consequence of an increased diffuse staining of
both TGN38 and syntaxin 6 as expected upon BFA treatment
(Figure 7A). Summarized, the data indicate that BFA traps PICK1
in the TGN and thus that PICK1 might be recruited to the TGN
before localizing to Golgi proximal structures. This observation
would be consistent with a role of PICK1 in budding of immature
vesicles from the Golgi and thereby a function that parallels the
role of other membrane-sculpting BAR domain proteins in
budding processes such as clathrin-mediated endocytosis [12,13].
To provide further evidence that PICK1 is recruited to the
TGN to participate in the vesicle budding process and to
investigate the kinetic behavior of PICK1, we first expressed in
GH1 cells PICK1 tagged N-terminally with GFP (green fluores-
cent protein). Unfortunately, overexpressed GFP-PICK1 localized
diffusely in GH cells consistent with the previously described
autoinhibition of the PICK1 BAR domain [18]. However,
truncation of the N-terminal PDZ domain relieves this autoinhibi-
tion, and indeed YFP-PICK1 BAR showed punctate localization
in GH cells, with many punctae lining the Golgi compartment
(identified by expression of the Golgi marker GalT, b1,4-
galactosyltransferase) [36] tagged with cerulean fluorescent protein
(GalT-Cerulean) (Figure S7). In contrast, a YFP-PICK1 BAR
mutant with strongly reduced lipid binding capacity (3KE) [17,18]
showed diffuse localization in the cells (Figure S7). Live confocal
Figure 5. PICK1 deficiency leads to loss and altered localization of DCVs in the pituitary. (A) PICK1 is expressed in GH-producing cells of
the pituitary. Confocal images of 15 mm slices from the pituitary of WT (+/+) (top) and PICK1-deficient mice (2/2) (bottom), immunostained for PICK1
(green) and GH (red). Insets show cells with characteristic intense arc-shaped distribution of GH and partial overlap with PICK1. Scale bar, 10 mm.
Pictures are representative of stainings of seven pituitaries from WT and PICK1-deficient mice. (B) The number of DCVs is reduced in pituitary cells
from PICK1-deficient mice. Transmission electron micrographs of uranyl acetate and lead citrate-stained ultrathin slices from the pituitary of WT (+/+)
(top) and PICK1-deficient mice (2/2) (bottom). Scale bars, left, 20 mm. Pictures are representative of several pictures from five WT (+/+) and four
PICK1-deficient (2/2) mice. (C) Quantification of the number of DCVs in 26 cells from WT (+/+) and 29 cells from PICK1-deficient (2/2) mice.
**Average significantly different from control, p=0.0022 in Student’s t test. (D) Size distribution of DCVs in GH cells of the pituitary is unaltered in
PICK1-deficient mice. The data show the relative frequency of different sizes of DCV in cells from PICK1-deficient mice (black) (n= 3,798) and in cells
from WT mice (white) (n= 7,021).
doi:10.1371/journal.pbio.1001542.g005
PICK1 in Biogenesis of Secretory Vesicles
PLOS Biology | www.plosbiology.org 8 April 2013 | Volume 11 | Issue 4 | e1001542
Figure 6. PICK1 is localized to vesicles exiting the Golgi in cultured GH1 cells, and knockdown of PICK1 reduces GH immunosignal
in GH1 cells. (A) PICK1 is expressed in GH-producing GH1 cells, and PICK1 knockdown reduces GH content. Confocal images of GH1 cells
immunostained for PICK1 (blue) and GH (red). Cells transfected with shRNA against PICK1 are identified by obligate coexpression of green fluorescent
protein (EmGFP) (green) and are outlined. Insets (squares) show area with (i) no colocalization of PICK1 and GH and (ii) partial colocalization of PICK
and GH. Scale bar, 10 mm. (B and C) Quantification of PICK1 immunosignal (B) and GH immunosignal (C) in GFP-positive cells transfected with either
of two different shRNAs against PICK1 (52 and 53). Data are % of signal in surrounding non-transfected cells (mean 6 SE) for control shRNA
(shControl) (n= 48), shPICK1 (52) (n= 69), and shPICK1 (53) (n= 75). ***p,0.001, compared to shControl, Mann–Whitney rank sum test. (D)
Quantification of the PICK1 co-localization with GH using Van Steensel’s cross-correlation function, which reports the Pearson cross-correlation as a
function of the relative movement of the two channels with respect to each other. The low but sharp peak close to Dx = 0 indicates partial but
specific co-localization. (E) Co-localization of PICK1 with Giantin, TGN38, and syntaxin 6. Confocal laser scanning micrographs of GH1 cells
immunostained for endogenous PICK1 (red) and the cis-Golgi marker giantin (top), the trans-Golgi (TGN) marker TGN38 (middle), and the TGN/
immature vesicle marker syntaxin 6 (bottom) (all in green). Insets highlight area where the PICK1 signal was either enclosed by, or closely associated
with, the Golgi markers (giantin, top, and TGN38, middle) or partially co-localizing (syntaxin 6, bottom). (F) Quantification of PICK1 colocalization with
giantin, TGN38, and syntaxin 6 using Van Steensel’s cross-correlation function. The broad peak for giantin is characteristic for large adjacent
structures, whereas the high and sharp peak close to Dx = 0 for syntaxin 6 indicates specific co-localization. TGN38 is intermediate between these
distributions, suggesting a partial overlap of the structure with PICK1. Co-localization was quantified for 10–20 cells from three independent
experiments, and data are means 6 SE. (G) Dashed box (left) from (E, Bottom) with magnification and gain adjusted for visualization of the punctate
staining of PICK1 (red) and syntaxin 6 (green). Intensity profile (right) through several punctae (white line in lower, merged picture on the left) shows
peaks corresponding to punctae for both PICK1 and syntaxin 6. All immunocytochemistry data were obtained from at least three independent
experiments, and the cells are representative of multiple cells imaged in each experiment.
doi:10.1371/journal.pbio.1001542.g006
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Figure 7. PICK1 associates transiently with the Golgi compartment and is capable of tubular deformation of liposomes in vitro. (A)
Brief (5 min) brefeldin A treatment traps PICK1 in the trans-Golgi. Confocal images of GH1 cells immunostained for PICK1, and the trans-Golgi marker
TGN38, and the trans-Golgi/immature vesicle marker syntaxin 6 before (top) and after 5 min BFA treatment (bottom). Panels show from left signal
from immunolabeled PICK1 (Alexa Fluor 568 signal), signal from TGN38 (Alexa Fluor 488 signal), signal from syntaxin 6 (Alexa Fluor 647 signal), and
overlay of the three channels. Insets highlight an area with overlapping localization of PICK1 and syntaxin 6 but with PICK1 adjacent to TGN38 (top)
and colocalization of PICK1 with both syntaxin and TGN38 (bottom). (B) Quantification of the PICK1 colocalization with TGN38 and syntaxin 6 after
5 min BFA treatment using Van Steensel’s cross-correlation function, which reports the Pearson cross-correlation as a function of the relative
movement of the two channels with respect to each other. Both syntaxin 6 and TGN38 show a sharp peak of similar height close to Dx = 0, indicating
specific co-localization. Co-localization was quantified for 10–20 cells from three independent experiments, and data are means 6 SE. Note that the
drop in peak values compared to no BFA (Figure 6F) likely reflects the increased diffuse localization of both markers after BFA treatment. (C) Fast
time-lapse dual color live confocal imaging showing transient association of YFP-PICK1 BAR with the Golgi marker GalT-Cerulean. Images are maximal
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imaging of cells co-expressing YFP-PICK1 and GalT-Cerulean
revealed a highly dynamic behavior of the YFP-PICK1-positive
punctae, in particular in the area lining the Golgi compartment, as
illustrated by the maximal intensity projection of the time series
(Figure 7C). In addition, we frequently observed transient events of
punctate structures appearing transiently at the edge of the Golgi
compartment. In Figure 7C, events lasting for less than 10 frames
(,30 s) are indicated by white dots, whereas stable punctate
structures (.10 frames) are indicated by crosses (see also Movie
S1). Of the transient events, seven out of 10 occurred at the edge of
the Golgi compartment, and two of these events are shown as time
series (1 and 2) in Figure 7D. The punctate structures appeared in
many cases to originate from protrusions from the Golgi,
suggesting that YFP-PICK1 BAR associates with vesicles
budding from the Golgi apparatus (Figure 7D). Whether PICK1
dissociates from the newly formed vesicles within the 30 s time
frame or whether the vesicles diffuse out of the plane could not
be determined. Interestingly, introduction of two negative
charges on the hydrophobic face of a putative N-terminal helix
of the PICK1 BAR domain (PICK1 BAR V121E-L125E) did
not change the punctate localization (Figures S7 and 7C);
however, most punctae appeared stable (indicated by crosses in
Figure 7C) and we did not see any transient events at the edge of
the Golgi during the time lapses (Figure 7E and Movie S2). This
suggests that V121E-L125E unlike the 3KE mutant is capable of
localizing to and clustering at the Golgi but unable to dissociate
from it. Notably, it was recently suggested that N-terminal
amphipathic helices in BAR domains might facilitate fission
events [37]. Summarized, the data demonstrate that the PICK1
BAR domain gets recruited to the Golgi and associates with
vesicles that bud from the Golgi network. This further
substantiates the idea that PICK1 is critical during the early
stages of secretory vesicle formation.
We next asked whether the PICK1 BAR domain is capable of
sculpting membranes and thus potentially contributes directly to
the budding process. We incubated in vitro the isolated and purified
PICK1 BAR domain with surface-immobilized artificial giant
membrane vesicles. Confocal imaging showed that the PICK1
BAR domain indeed pulled tubular structures from the vesicles,
whereas PICK1 BAR V121E-L125E had no observable effect
(Figure 7F). Unfortunately, we could not test the effect of PICK1
BAR 3KE because it expressed poorly in the bacteria, making it
impossible to obtain sufficient amount of pure protein for the
experiment (unpublished data).
PICK1 Exists in a Complex with ICA69 and PICK1-
Deficiency Abolishes ICA69 Protein Expression in Mice
and Drosophila
The cellular localization of PICK1 partially resembled that of
the closely related BAR domain protein ICA69 [22], previously
suggested to associate with PICK1 in neurons via BAR domain
heterodimerization [19]. Indeed, ICA69 was expressed in GH1
cells and showed striking colocalization with PICK1 (Figure 8A) as
also reflected in the cross-correlation analysis revealing a sharp
peak at Dx= 0 with a maximum .0.8 (Figure 8B). Moreover,
ICA69 and PICK1 co-immunoprecipitated in extracts from GH1
cells, supporting that the two proteins form a heterodimeric
complex (Figure 8C–D). Interestingly, knockdown of PICK1
expression in GH1 cells caused a parallel robust decrease in the
ICA69 protein level, as evidenced by a marked decrease in
immunoreactivity (Figure 8A,E,F). We also assessed ICA69
expression in ATT20 cells, and similar to our observations in
GH1 cells, there was significant ICA69 immunostaining overlap-
ping with the PICK1 signal (Figure S8A). Furthermore, knock-
down of PICK1 in ATT20 cells significantly reduced ICA69
immunoreactivity (Figure S8B–C).
These observations in GH1 cells led us to investigate ICA69
expression and localization in the pituitary of WT and PICK1-
deficient mice by immunohistochemistry. In WT mice, the ICA69
immunosignal clearly overlapped with the PICK1 signal both at
the cellular and subcellular levels (Figure 8G). Strikingly and
consistent with our findings in GH1 cells, we were unable to detect
ICA69 expression in PICK1-deficient mice by immunohistochem-
istry (Figure 8G). This lack of ICA69 protein expression was
confirmed by Western blotting of pituitary extracts from PICK1-
deficient mice (Figure 8H) and was not caused by reduced
transcription (Figure 8I). To assess whether PICK1-dependency of
ICA69 expression is evolutionary conserved, we expressed
Drosophila ICA69 tagged with hemagglutinin (HA) in peptidergic
neurons of WT and PICK1 null flies. In WT neurosecretory
neurons, the immunoreactivities of exogenous ICA69-HA and
endogenous PICK1 overlapped extensively (Figure 9A). In flies co-
expressing ICA69-HA and PICK1A under the control of the pan-
neuronal elav-GAL4 driver, we were also able to co-immunopre-
cipitate the two proteins (Figure 9B–C). Furthermore, the ICA69
immunosignal was dramatically reduced in PICK1-null flies
(Figure 9D). We next tested the converse possibility that the
PICK1 protein level depends on the ICA69 level, by knocking
down ICA69 expression with a UAS-ICA69-RNAi construct.
ICA69-RNAi markedly reduced endogenous PICK1 staining, with
no change in control brains (Figure 9E). Likewise, Western blots
showed a severe drop in the PICK1 immunosignal in ICA69-
RNAi flies compared to controls (Figure 9F–G). RT-PCR analysis
verified reduced ICA69 mRNA levels in ICA69-RNAi flies,
whereas PICK1 mRNA levels were unaffected (Figure 9H).
Conversely, in PICK1-null flies ICA69 mRNA was not reduced,
whereas PICK1 mRNA was hardly detectable (Figure 9I). We
finally tested whether the mutual interdependency of PICK1 and
ICA69 expression could be reproduced in GH1 and ATT20 cells.
This was indeed the case, as shRNA-mediated knockdown of
intensity projections of representative time-lapse series for YFP-PICK1 BAR (left), YFP PICK1 BAR V121E-L125E (middle), and YFP-PICK1 BAR 3KE (right).
The gray scale projections (left images) show the YFP channel alone, indicating highly dynamic behavior of YFP PICK1 BAR (left) and more static
behaviour of YFP-PICK1 BAR V121E-L125E (middle) punctae, whereas no punctae are seen for YFP-PICK1 BAR 3KE (right). The dual color projections
(right images, YFP channel in yellow, Cerulean channel in blue) show that most of the activity for YFP-PICK BAR (left) is lining the Golgi, whereas YFP-
PICK1 BAR V121E-L125E (middle) shows activity throughout the cell. Circles indicate transiently appearing punctate structures (lasting for less than 10
frames, ,30 s). Crosses indicate stable punctate structures lasting for more than 10 frames. (D) Time-lapse series of two transient punctate structures
of YFP-PICK1 BAR, and (E) two stable punctate structures of YFP-PICK1 BAR V121E-L125E. Scale bar, large images 5 mm, time lapse 1 mm. (F)
Tubulation of surface-immobilized artificial giant membrane vesicles by the PICK1 BAR domain. Purified and Alexa Fluor 488–labeled GST-PICK1 BAR
or GST-PICK1 BAR V121E-L125E (control) with impaired membrane binding capacity. Protein was incubated at room temperature with surface
immobilized and fluorescently labeled vesicles before confocal fluorescent imaging. No effect was seen for the mutant, whereas massive tubulation
was seen with GST-PICK1 BAR. Arrow indicates a budding vesicle from a single GV.
doi:10.1371/journal.pbio.1001542.g007
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Figure 8. ICA69 expression is dependent on PICK1, and the two proteins co-localize and co-immunoprecipitate. (A) PICK1 co-localizes
with ICA69. Confocal images of GH1 cells immunostained for PICK1 and ICA69. Cells transfected with shRNA against PICK1 are identified by obligate
co-expression of EmGFP and are outlined. Insets demonstrate extensive PICK1 and ICA69 colocalization. Pictures are representative of multiple cells
imaged in three independent experiments. Scale bar, 10 mm. (B) Quantification of co-localization between ICA69 and PICK1 using Van Steensel’s
cross-correlation function, which reports the Pearson cross-correlation as a function of the relative movement of the two channels with respect to
each other. In agreement with striking co-localization, the analysis revealed a sharp peak at DX=0 with a maximum .0.8. Co-localization was
quantified for 10–20 cells from three independent experiments, and data are means 6 SE. (C) Western blotting with chicken anti-PICK1 antibody of
immunoprecipitates obtained with mouse anti-PICK1 2G10 antibody in GH1 cells lysates. Left lane, lysate input; middle lane, no 2G10 antibody. (D)
Co-immunoprecipitation of ICA69 with PICK1. Western blotting with rabbit anti-ICA69 antibody of immunoprecipitates obtained with mouse anti-
PICK1 2G10 antibody in GH1 cells lysates. Left lane, lysate input; middle lane, no 2G10 antibody. (E and F) Quantification of immunosignal of ICA69 (B)
and of PICK1 (C) in GFP-positive cells transfected with either of two different shRNAs against PICK1 (52 and 53). Data are percent of expression in
surrounding nontransfected cells (means 6 SE) for control shRNA (shControl) (n= 61), shPICK1(52) (n= 85), and shPICK1 (53) (n= 75). ***p,0.001 as
compared to shRNA control, Mann–Whitney rank sum test. (G) ICA69 is expressed in GH-producing cells of the pituitary and co-localizes with PICK1 in
WT mice but is absent in cells from PICK1-deficient mice. Arrows show examples of extensive PICK1/ICA69 co-localization in WT mice. Scale bar,
10 mm. Pictures are representative of stainings of seven pituitaries from WT and PICK1-deficient mice. (H) ICA69 immunoreactivity is essentially absent
in PICK1-deficient mice. Western blots of pituitary extracts from WT and PICK1-deficient mice (three representative of each) using rabbit anti-ICA69
antibody and anti-PICK1 2G10 antibody. (I) Similar ICA69 mRNA levels in WT and PICK1-deficient mice. Quantification by RT-PCR of ICA69 mRNA in the
pituitary from WT and PICK1-deficient mice. Mice of 35–38-wk-old were used. White bars, PICK1+/+: black bars, PICK1 2/2. Data are means 6 SE
(n=7–10).
doi:10.1371/journal.pbio.1001542.g008
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ICA69 led to a parallel decrease in apparent PICK1 expression in
both cell lines (Figures S8D–F and S9A–C).
Together, the data suggest that PICK1 might exert its function
in a heterodimeric complex with ICA69 and that the two proteins
stabilize one another. The ability of PICK1 to stabilize expression
of ICA69 was supported by expression of the proteins in a non-
endocrine cell line. Flp-In T-REx 293 cells stably expressing HA-
tagged ICA69 (HA-ICA69) in a tetracycline-dependent manner
(Flp-In T-REx 293 HA-ICA69 cells) were transfected with YFP-
PICK1 or empty plasmid before induction of the cells with
tetracycline for 24 h. Western blotting revealed several folds
higher ICA immunoreactivity in YFP-PICK1-expressing cells
compared to control cells (Figure S10).
Finally, we investigated whether PICK1 together with ICA69
might have a general role in the formation of secretory vesicles.
Previously, it was shown that expression of chromogranin A (CgA)
in non-endocrine cells can lead to formation of dense core-like
granules in non-endocrine cells, consistent with the functional
importance of chromogranins in secretory vesicle formation
[1,6,7]. If, as suggested by our data, PICK1 together with
ICA69 function to facilitate the formation of secretory vesicles, we
hypothesized that co-expression of PICK1 and ICA69 together
with CgA should promote formation of CgA-positive vesicles in
non-endocrine cells. First, we expressed PICK1 fused to GFP
(GFP-PICK1) and HA-ICA69 either alone or together in COS7
cells. When expressed alone, the resulting GFP-PICK1 and HA-
ICA69 immunosignals were relatively uniformly distributed in the
cytoplasm showing little co-localization with the Golgi marker
giantin (Figure 10A). However, when expressed together, the GFP-
PICK1 and HA-ICA69 immunosignals clustered around the
nucleus and showed marked overlap with the giantin immuno-
signal (Figure 10A). When expressed alone in COS7 cells, CgA
fused to GFP (CgA-GFP) localized primarily to a Golgi-like
juxtanuclear compartment with little localization to punctate
structures in the cytoplasm (Figure 10B), a localization that was
confirmed in giantin co-stainings (unpublished data). However,
Figure 9. Interdependent expression of PICK1 and ICA69 in Drosophila. (A) Immunostainings for ICA69 and PICK1 in a single peptidergic
neuron in the protocerebrum of adult Drosophila brain. HA-tagged ICA69 targeted to peptidergic cells (c929-GAL4/+; UAS-ICA69-HA/+) was detected
in parallel with endogenous PICK1. Arrows indicate examples of PICK1/ICA69 co-localization. Scale bar, 10 mm. (B and C) Drosophila ICA69-HA co-
immunoprecipitates PICK1 from fly head extracts. Flies were co-expressing ICA69-HA and PICK1 under the pan-neuronal elav-GAL4 driver (elav-GAL4/+;
UAS-ICA69-HA/UAS-PICK1A). (B) Immunoprecipitation (IP) with anti-HA antibody and immunoblotting (IB) with anti-PICK1 antibody. Left lane, control
without antibody; right lane, lysate. (C) Immunoprecipitation (IP) with rat anti-HA antibody (3F10) and immunoblotting (IB) with mouse anti-HA (16B12)
antibody. Left lane, control without antibody; right lane, lysate. (D) Dependence of ICA69 expression on PICK1 expression in Drosophila. ICA69-HA
immunoreactivity is shown in control brain (c929-GAL4, PICK1/+; UAS-ICA69-HA/+) and in PICK1-null mutant brain (c929-GAL4, PICK1/PICK2; UAS-ICA69-HA/
+). pi, pars intercerebralis; pc, protocerebrum; ol, optic lobe. Pictures are representative of six fly brains stained in three experiments. (E) Dependence of
PICK1 expression on ICA69 expression in Drosophila. PICK1 immunosignal in control brain without RNAi transgene (ELAV-GAL4/UAS-DCR2;;TM3/+) and in
brain with pan-neuronal expression of ICA69 hairpin RNA (ELAV-GAL4/UAS-DCR2;;UAS-ICA-RNAi/+) (ICA69-RNAi). Scale bar, 100 mm. Pictures are
representative of six fly brains stained in three experiments. (F) Western blotting of head extracts from control and ICA69 RNAi flies. (G) Quantification of
the data in (F). Protein levels are normalized to ELAV. Data are means 6 SE, n=6, p,0.05. (H and I) Quantification by RT-PCR of ICA69 mRNA (H) and
PICK1 mRNA (I) levels in heads from ICA69 knockdown (ICA69-RNAi), PICK11, and control flies. Data are means 6 SE, n=6 for control and ICA69-RNAi,
n=4 for PICK11, *p,0.05, **p,0.01.
doi:10.1371/journal.pbio.1001542.g009
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when GFP-PICK1 and HA-ICA69 were expressed together with
CgA-GFP, we observed a remarkable redistribution of CgA-GFP.
Now, CgA-GFP localized to a much higher degree to punctate
structures in the cytoplasm, possibly representing CgA containing
vesicles (Figure 10B). Quantification showed that the punctate
signal relative to total signal increased almost 3-fold (Figure 10C),
consistent with the concept of a direct role of the PICK1/ICA69
complex in formation of CgA containing vesicles. Notably, the
majority of the immunosignal from GFP-PICK1 and ICA69 was
seen in the Golgi-like juxtanuclear compartment and little co-
localization of GFP-PICK1 and HA-ICA69 with CgA in vesicular
structures. Importantly, this is agreement with our observation for
GH-positive vesicles in GH-1 cells; that is, PICK1 and ICA69
localize primarily to the early secretory vesicles and not necessarily
to the mature vesicles.
Altered Expression of PICK1 in Models of Metabolic
Diseases
Given the profound metabolic changes in PICK1-deficient flies
and mice, we wanted to assess whether PICK1 might be linked to
metabolic pathophysiology. First, we used a Drosophila model of
T2D, in which larvae are grown on a high-sugar diet (HSD). As a
consequence of the HSD, they develop hyperglycemia, insulin
resistance, and other hallmarks of human T2D. Moreover, larval
development under HSD is considerably delayed due to the
resistance of the peripheral tissues to the dILPs, which control
Drosophila growth and sugar homeostasis (Figure 11A) [38–40]. In
both flies and mammals, peripheral insulin resistance is associated
with a compensatory increase in production and secretion of
insulin peptides [38–40]. If PICK1 is important in the biogenesis
of insulin/dILP-containing vesicles, PICK1 expression might be
altered in response to HSD. Confirming earlier reports [38–40],
we found that rearing larvae on HSD markedly delayed their
development. More importantly, when assessing PICK1 mRNA
expression in the heads of the adult flies, we observed ,50% up-
regulation of PICK1 mRNA in flies reared on HSD during their
development as compared to control flies (Figure 11B).
To study the involvement of PICK1 in a mammalian model of
metabolic syndrome, we used adult (18-wk-old) male mice fed a
60% high-fat diet for 12 wk. This model (diet-induced obesity,
DIO is a well-described tool for studying human metabolic
syndrome [41]. The deregulated glucose metabolism was verified
by decreased oral glucose tolerance, increased fasting glucose, and
increased fat mass (Figure 11C–D) as well as increased basal and
glucose-stimulated plasma insulin levels (basal insulin,
115617 pg/mL in control mice and 1,1106170 pg/mL in DIO
mice p,0.0001; glucose stimulated insulin, 1,8306190 pg/mL in
control mice and 7,4606970 pg/mL in DIO mice, p#0.0001).
Because GH is secreted in a pulsatile manner, we measured
plasma IGF-1 as marker of total GH secretion [25] and found a
trend towards an increase in the DIO mice (Figure 11E).
Interestingly, we also found that the PICK1 mRNA expression
level in the pituitary was significantly up-regulated by ,15% in
the DIO mice (Figure 11F). Thus, PICK1 expression is both in
flies and mice sensitive to changes in metabolic states that mimic
the human metabolic syndrome.
Discussion
The present study suggests that the membrane-sculpting BAR
domain protein PICK1 serves an important and hitherto unknown
role in endocrine physiology by controlling the efficiency of dense
core secretory vesicle biogenesis in peptidergic endocrine cells.
Our initial key observation is that flies and mice that are deficient
in PICK1 display marked somatic growth retardation. In the flies,
we can link this phenotype to absence of PICK1 from peptidergic
neurons secreting somatotropic peptides functionally equivalent to
GH and insulin in mammals. In the mice, we can link the
phenotype to impaired storage and secretion of GH from the
pituitary and likely also of insulin from the pancreas. At the
cellular level, EM analysis of mouse pituitary showed that PICK1
deficiency leads to a prominent decrease in the pool of secretory
vesicles. There was no apparent change in vesicle size and
appearance, which is consistent with a simple decrease in the rate
of secretory vesicle formation. To exclude possible effects of
deficient hypothalamic regulation, we also knocked down PICK1
expression in GH1 cells, an immortalized GH-producing cell line.
This procedure markedly reduced apparent GH levels, in
agreement with our observations in the pituitary.
Co-localization studies suggested that PICK1 primarily is
localized adjacent to the Golgi, and we observed strong co-
localization with syntaxin 6 that marks immature vesicles budding
from the TGN [34]. Our co-localization experiments were
quantitatively strongly supported by application of Van Steensel’s
cross-correlation analysis [33], although we should note that
despite the outcome of this analysis, the experiments do not
exclude that PICK1 and ICA69 might reside in yet unidentified
compartments as well. Nonetheless, it was striking to observe how
a brief brefeldin A treatment enhanced co-localization with TGN,
suggesting that PICK1 transiently associates with this compart-
ment. In addition, we could show by live imaging of GH1 cells that
the WT PICK1 BAR domain gets recruited to the Golgi and
dynamically associates with vesicles that bud from the Golgi
network. Together with the ability of the PICK1 BAR domain to
tubulate membranes in vitro, these observations support a direct
involvement of PICK1 in budding of GH containing vesicles from
the TGN.
Our phenotypic analysis of PICK1-deficient mice demonstrated
classical characteristics of GH deficiency, including decreased
body weight and length, increased body fat accumulation, less lean
body mass, reduced ghrelin-induced GH secretion, reduced liver
weight, and decreased IGF-1 expression substantiated both by
decreased plasma levels and lower mRNA expression in the liver
[42]. An even more severe metabolic phenotype of PICK1-
deficient mice was suggested by decreased glucose tolerance
combined with impaired glucose-induced insulin secretion. These
observations agree with those of Xia and colleagues showing
impaired insulin secretion from b-cells in the pancreas of PICK1-
deficient mice [29]. Xia and colleagues did not, however, observe
Figure 10. PICK1 and ICA69 co-localize in the Golgi compartment of COS7 cells and promote punctate distribution of GFP-tagged
chromogranin A (CgA-GFP) in the cytosol. (A) Confocal images of COS-7 cells transfected with GFP-PICK1 (top), HA-ICA69 (middle), or GFP-PICK1
and HA-ICA69 (bottom). From left, the channels show GFP-PICK1 in green, HA-ICA69 in red, and endogenous giantin in blue. Upon co-expression,
GFP-PICK1 and ICA69 co-localize with giantin in the Golgi compartment. Scale bar, 10 mm. (B) Confocal images of COS-7 cells transfected with CgA-
GFP and pcDNA3 (top) or together with mycPICK1 and HA-ICA69 (bottom). From left, the green channel shows CgA-GFP, the red channel shows
mycPICK1, and the blue channel shows HA-ICA69. Insets illustrate the marked increase in punctuate CgA structures in cells co-transfected with
mycPICK1 and HA-ICA69. Outlines of the cells are shown in the green channel in white. Scale bar, 10 mm. Images are representative of n= 50 (CgA-
GFP) and n= 44 (CgA-GFP+mycPICK1+HA-ICA69) cells from three independent sessions. (C) Quantification of the punctuate CgA-GFP signal relative to
the total CgA-GFP signal as a measure of the efficiency of Golgi exit. ***p,0.001 in Student’s t test.
doi:10.1371/journal.pbio.1001542.g010
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increased insulin sensitivity. Furthermore, they found a small but
significant increase in daily food and water intake of the PICK1-
deficient mice [29], where we observed a tendency toward an
increase. We have no immediate explanation for these apparent
discrepancies other than they might be caused by slight differences
in the experimental procedures and the fact that the PICK-
deficient mice, although derived from the same knock-out strain,
have been maintained separately. It is important to note that
increased insulin sensitivity indeed is known to be associated with
impaired GH function [27]. In further agreement with impaired
GH function and increased insulin sensitivity, we identified an up-
regulation of insulin receptor protein levels in the liver [43,44].
To assess the importance of the GH deficiency for the metabolic
phenotype, we administered GH to PICK1-deficient mice, and we
observed an increase in lean body mass approaching WT levels
within 2 wk. After the treatment, insulin sensitivity was similar to
that of WT mice, and IGF1-mRNA expression levels were not
significantly different from WT animals. In the glucose tolerance
test, we saw no signs of recovery, suggesting that the decreased
glucose-induced insulin secretion observed in the PICK-deficient
mice is independent of the GH-deficient phenotype. On the other
hand, GH treatment is known to be diabetogenic and could
negatively affect the glucose tolerance [27]. It remains nevertheless
an open question whether PICK1 is critical for secretory vesicle
biogenesis in peptide-producing endocrine cells in general. In the
pituitary, we observed a significant decrease also in prolactin
content, but only a trend was seen for ACTH and TSH. However,
knockdown of PICK1 in ACTH-producing ATT20 cells led to a
significant decrease in apparent ACTH levels, showing that
PICK1 might be important for ACTH secretion at least in isolated
cells. A more general role of PICK1 in peptide hormone secretion
is therefore possible, and it is important to keep in mind that in the
PICK1 knock-out mice, adaptive changes occurring during
development might compensate for the absence of PICK1 in
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Figure 11. Up-regulation of PICK1 expression in Drosophila under HSD that induces peripheral dILP resistance. (A) Delayed larval
development in response to HSD that induces peripheral dILP resistance [38,39]. WT flies were allowed to deposit eggs on an apple juice plate for
6 h. On the following day, first instar larvae hatched from the eggs were transferred to vials either containing food with the standard amount of
sucrose (left) or five times that amount (right). Photographs were taken 6 d following oviposition. Note that, when all the larvae in the vials
containing standard food have already left the food, completed the wandering stage, and commenced pupariation (left, vertical arrows), the larvae in
the vials with 56 sucrose have yet to leave the food to commence the wandering stage (right, horizontal arrows). (B) Quantitative RT-PCR was
performed on pooled heads from fully developed adult female flies reared on standard food (n=9 samples) or food with five times the normal
amount of sucrose (n= 7). Data show relative change (means 6 SE). **p,0.01. (C) Impaired glucose tolerance in high-fat-diet-induced obese C57BL
mice (DIO). OGTT was performed on DIO mice (black squares) and littermate controls fed on a normal chow diet (white squares). After 16 h fasting,
the DIO mice displayed increased glucose level compared to control mice (6.160.3 mM versus 4.460.2 mM; p= 0.0006), and after the glucose load,
the blood glucose level was significantly higher at any time point (p#0.001). (D) The DIO mice also displayed significantly higher fat mass compared
to control mice (12.660.6 g versus 1.4860.21 g; ***p#0.0001). (E) Total plasma level of IGF-1 in DIO mice (510659 ng/mL) compared to control mice
(393637 ng/mL) (p= 0.11). (F) The relative expression of PICK1 mRNA assessed by RT-PCR was increased in the pituitaries of DIO mice. All
measurements were performed on n= 14 high-fat-diet-treated mice and 14 mice fed a normal chow diet and data are expressed as means 6SE.
doi:10.1371/journal.pbio.1001542.g011
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some systems and not in others, maybe depending on the turnover
rate of the secretory vesicle pool.
It is interesting that PICK1 deficiency does not completely
deplete the pool of secretory vesicles in the GH-producing cells.
This indicates that PICK1 serves primarily to accelerate vesicle
formation, trafficking, and maturation. Such a role would also be
compatible with previous studies stressing that other cellular
components are important for driving TGN vesicle budding and
formation. Cholesterol has been proposed to play a role via its
ability to promote formation of membrane rafts on the cholesterol-
enriched maturing face of the TGN [1,5]. Moreover, chromo-
granins, which are present in secretory vesicles of all neuroendo-
crine cells, were suggested to constitute a driving force for vesicle
budding [1,6,7]. Chromogranins aggregate together with prohor-
mones at conditions corresponding to those inside the TGN (i.e.,
at low pH in the presence of Ca2+), and the budding process might
be stimulated by associations of these aggregates with membrane
rafts [1,6,7]. Remarkably, we could show that co-transfection of
PICK1 and ICA69 promotes punctate localization and possibly
vesicular storage of chromogranin in non-endocrine COS7 cells,
supporting the interesting possibility that chromogranins operate
together with the PICK1/ICA69 complex in the biogenesis of
secretory vesicles. Hence, PICK1 might, together with ICA69,
associate with cholesterol-enriched microdomains on the maturing
face of the TGN and thereby impose the necessary bending of the
lipid bilayer.
In the accompanying paper, Xia and colleagues propose that
PICK1 and ICA69 are associated primarily with immature
vesicles positive for proinsulin, while PICK1 alone is associated
with mature insulin-positive vesicles [29]. We did not find
evidence for this distinction in GH1 cells where the co-localization
between the two proteins is remarkable, with a Pearson cross-
correlation value .0.8. Possibly, there is a functional difference
between the two different types of endocrine cells. An important
difference is that biosynthesis of insulin involves conversion of
proinsulin to insulin, which is not the case for GH. Of note,
because the vesicle maturation process involves conversion of
proinsulin to insulin, it is possible in insulin-producing cells to use
the proinsulin level as a measure of secretory vesicle maturation,
which cannot be done in GH-producing cells.
BAR domain proteins have previously been implicated in other
budding processes such as clathrin-mediated endocytosis. Current
insights suggest that at least four different BAR domain proteins
including the FCHO1/2, SNX9, amphiphysin, and endophilins
are involved. Recently, it was demonstrated that FCHO1/2 is
required for induction of the initial membrane curvature and
thereby for nucleation of clathrin-coated pit formation [12,13]. In
subsequent steps, amphiphysin is believed to play a role in
membrane bending and dynamin recruitment to clathrin-coated
pits, SNX9 in AP2 and dynamin binding, and endophilins in
dynamin and synaptojanin recruitment [12,13]. However, al-
though both endocytosis and secretory vesicle biogenesis involve
vesicle budding, there are also inherent differences between the
two processes. For example, the putative driving force provided by
a high density of prohormones and chromogranins inside the
TGN is not available for endocytosis [1]. Thus, the present data
extend the role of two BAR domain proteins to a vesicle-budding
process that is different in nature from that of clathrin-mediated
endocytosis. An interesting question is whether other BAR domain
proteins are involved in addition to PICK1 and ICA69.
With the exception of a function in acrosome biogenesis [45],
PICK1 has been known almost exclusively for its roles in
regulating trafficking and phosphorylation of membrane proteins
in the CNS [14–17,46]. Hence, our data reveal a remarkable
functional diversity of the PICK1 protein by identifying a so far
unknown evolutionary conserved function. PICK1 is known
particularly for regulating surface levels and subunit composition
of AMPA-type glutamate receptors, and thereby for synaptic
plasticity including both long-term depression (LTD) and long-
term potentiation (LTP) as well as other types of plasticity [14–
17,46–50]. Despite the convincing evidence for these conclusions,
it is interesting to consider that the role of PICK1 in synaptic
plasticity might also depend on its role in controlling secretory
vesicle biogenesis. PICK1 may be involved in storage and
secretion of, for example, neurotrophic factors, such as BDNF
(brain-derived neurotrophic factor), which are known to play an
important role in regulating synaptic plasticity [51].
PICK1 co-localized and co-immunoprecipitated with the
homologous BAR domain protein ICA69 that differs from PICK1
by not having an N-terminal PDZ domain [19]. We also observed
that ICA69 protein expression was strongly dependent on PICK1
in mice, GH1 cells, ATT20 cells, and the Drosophila brain. In FlpIn
293 cells without a regulated secretory pathway, PICK1 enhanced
ICA69 protein expression, adding further support to a direct
stabilizing role of PICK1. In GH1 cells, ATT20 cells, and flies, we
could demonstrate the reciprocal dependency; that is, knockdown
of ICA69 reduced PICK1 protein expression. Altogether, the data
support that PICK1 exerts its function in a heterodimeric complex
with ICA69. This agrees with previous observations indicating
heterodimerization of PICK1 with ICA69 in neurons [19]. Of
interest, ICA69 was proposed to be involved in regulating
secretion from neurosecretory cells [22] and was also shown to
be an effector of the small GTPase Rab2 [52,53]. Future
experimental efforts should further clarify the functional impact
of the PICK1/ICA69 interaction.
Because of the severe endocrine dysfunction and changed
metabolic homeostasis that we observe in PICK1-deficient mice,
we tested whether PICK1 expression might be altered in two
metabolic disease models, one in flies [38–40] and one in mice
[41]. In adult flies, reared during development on a HSD, PICK1
mRNA levels increase significantly, and correspondingly PICK1
mRNA levels in the pituitary increase in mice fed on a high-fat diet
(DIO mice). We also measured plasma IGF-1 levels in the DIO
mice as a marker of GH secretion and found a trend toward an
increase. Interestingly, a significant increase in circulating IGF-1
levels was found in a recent study on obese mice introduced to a
high-fat diet at a slightly younger age than the mice used on our
study [54]. Furthermore, it should be noted that evaluation of the
plasma level of free or total IGF-1 in obesity might be complicated
by factors such as IGF binding proteins and fat mass [55].
Summarized, PICK expression appears sensitive to metabolic
changes that characterize metabolic syndrome and/or T2D;
hence, it is possible that PICK1 plays a role in the pathophys-
iological process of metabolic diseases or in a protective
compensatory mechanism.
It is also striking that the phenotype of the PICK1-deficient
mice resembles the clinical symptoms associated with human GH
deficiency [42]. Congenital GH deficiency has an incidence of one
in 4,000–10,000 children, of which the majority is expected to be
caused by genetic factors. Nonetheless, the causative genetic defect
has only been identified in a small fraction of these patients [42].
Variants of the PICK1 and perhaps ICA69 could very well be
responsible for a subset of idiopathic GH-deficiency patients
characterized by decreased somatic growth and increased fat
accumulation. Finally, the identification of a BAR domain protein
as a key player in controlling storage and secretion of GH and
possibly other hormones should prove important for our general
understanding of secretory processes and potentially lead to the
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development of new treatments for diseases characterized by
impaired secretion of hormones.
Material and Methods
Drosophila Genetics and Molecular Biology
The PICK11 and PICK2 null alleles are identical to PICK1DEP-147
and PICK1DEP-197, respectively, which were generated by impre-
cise excision of the P-element EP2315, as described [20]. The
precise excision allele PICK1DEP-213, generated in the same jump-
out mutagenesis screen [20], was used as control (Figure 1).
Drosophila PICK1 is expressed as an A-form and a shorter B-form;
the P{w+ UAS-PICK1A-HA} insertion used in the present study
encodes the A-form and was generated earlier [20]. To produce
the P{w+UAS-PICK1A} insertion, a cDNA encoding the PICK1
A-form, amplified from clone RE18409 (Drosophila Genomic
Resource Center, Bloomington, IN), was inserted into the pCR-II-
TOPO vector (Invitrogen, Carlsbad, CA) and subcloned as a NotI-
KpnI fragment into the pUAST transformation vector [56].
Likewise, to produce the P{w+ UAS-ICA69-HA} insertion, full-
length CG10566 cDNA (Drosophila Genomic Resource Center,
Bloomington, IN) and sequence encoding a C-terminal hemag-
glutinin tag was inserted into pCR-II-TOPO and subcloned as a
NotI-KpnI fragment into pUAST. After sequencing, the pUAST
plasmids were injected into embryos (Bestgene Inc., Chino Hills,
CA). We used transformant ID 27281 (Vienna Drosophila RNAi
Center, Vienna, Austria) to knock down expression of the
CG10566 gene that encodes the Drosophila homologue of mam-
malian ICA69. To increase knockdown efficiency, we expressed
dicer-2 using P{w+ UAS-DCR-2.1}1 (Bloomington Stock Center,
Bloomington, IN). To drive expression of the UAS transgenes, the
following GAL4 insertions were used: P{GawB}dimm929 [57],
P{Ilp2-GAL4.R} [58], P{Akh-GAL4.L}2 [59], and P{GawB}elavC155.
When necessary, the various insertions were recombined onto
chromosomes carrying either other insertions, PICK11, or PICK2.
Flies were reared on standard cornmeal medium (or on HSD for
the metabolic experiments, see below) at 25uC at constant
humidity, except during knockdown of ICA69 where the flies
were kept at 28uC to maximize the effect of the RNAi construct.
For determination of Drosophila body weights, flies were taken as
progeny from vials seeded with 10 males and 10 females. One day
after enclosure, 3–8 flies were placed in a preweighed Eppendorf
tube and weighed. The weight of the tube was subtracted and the
result divided by the number of flies.
Mouse Genetics, Breeding, and Housing
The PICK1-deficient mice were generated as described [50].
The mice were backcrossed to C57BL/6 mice for three
generations, and then bred to homozygosity using littermate male
2/2 and +/+ mice throughout the study. Mice backcrossed for
more than 10 generations into C57BL/6 mice were used in
selected experiments. In these mice we observed a similar
reduction in body length, body weight, femur length, and GH
and prolactin content in the pituitary as in the strain backcrossed
for three generations. C57BL/6NTac mice (DIO mice) were
purchased from Taconic (Hudson, NY) after they had been kept
on a diet with 60% of the calories from fat for 10 wk from weaning
at 6 wk. The mice were kept under the same diet upon arrival to
University of Copenhagen and the next 2 wk. The lean control
mice were likewise purchased from Taconic (Hudson, NY) and
were at the same age and local breeding strain as the DIO mice.
All animals were maintained and experiments conducted in
accordance with institutional guidelines and approved by the
Animal Experiments Inspectorate in Denmark.
Measurement of Mouse Body Weight, Length, and
Composition
Body weight was measured in mice at time points indicated in
the figure legends. Body length between nose and tail root was
measured in anesthetized mice at 16–18 wk of age [60]. Body
composition was determined in live, unanesthetized animals by
quantitative magnetic resonance imaging using EchoMRI 4-in-1
(Echo Medical Systems, Houston, TX). Femoral length was
measured in mice at 39–41 wk of age. Mice were sacrificed and
right femur was excised. After carefully removing all the adhering
soft tissues, the length (cm) between the greater trochanter and
medial condyle was measured. Indirect calorimetry was performed
in a 16-chamber indirect calorimetry system (PhenoMaster: TSE
Systems, Bad Homburg, Germany) to examine PICK1-deficient
mice and WT mice at the age of 11–13 wk. Mice were individually
housed and placed in the chambers for 8 d; the first 5 d was
considered the acclimation phase, and data were analyzed only for
the last 3 d. Oxygen consumption rate (VO2: ml/h/kg fat free
mass), respiratory exchange ratio (RER), and food and intake were
simultaneously measured for each mouse.
Measurement of IGF-1, GH, and Other Pituitary
Hormones
Mice at the age of 35–38 wk were used to determine plasma
IGF-1 level. After an overnight fast, blood was collected from the
orbital sinus and plasma was separated for measuring IGF-1 with
ACTIVE Mouse/Rat IGF-1 RIA kit (Diagnostic Systems Labo-
ratories, Inc.). Ghrelin-induced GH secretion was assessed in mice
at the age of 7–9 wk. Fifteen minutes after anesthesia with
pentobarbital (i.p. 50 mg/kg body weight), 10 mg of ghrelin
(Polypeptide, Inc.) in 0.1 ml saline was injected i.p. Blood was
sampled from orbital sinus before and 5 min after injection [26].
Plasma GH concentration was measured using Rat/Mouse GH
ELISA KIT (Millipore) and plasma triglyceride (DT60II Model,
Orthoclinical Diagnostics; Sollentuna, Sweden). To determine the
total content of the protein level of pituitary-specific hormones, the
pituitaries from 34-wk-old mice were dissected and lysed in RIPA
Lysis buffer [1% Triton X-100, 150 mM NaCl, 10 mM Tris-HCl
(pH 7.5), 1 mM EDTA, 1% NP-40, complete mini Protease
Inhibitor Cocktail, ROCHE REF. 11836153001] and homogeni-
zied. Three different pituitary hormones were measured using
ELISA assay: GH (Millipore), prolactin and ACTH (Calbiotech),
and TSH (Phoenix Peptides, Burlingame CA). Expression levels of
GH and GH receptor mRNA were measured by quantitative real-
time PCR in pituitaries taken from mice 35–38 wk old. Insulin
receptor expression in liver samples was determined by Western
blotting analysis on samples homogenized in the previously
mentioned RIPA buffer. Protein extracts (20 mg/lane) were
separated on 10% SDS-PAGE and electroblotted to PDVF
membranes. Bands were quantified by densitometry (Alpha easy
Innotech software). Equal loading was ensured with use of ß-actin
antibody. The insulin receptor antibody was purchased from
Santa Cruz Biotechnology, Inc. (Santa Cruz, CA).
GH Treatment of PICK1-Deficient Mice
Recombinant human GH (rhGH) was a generous gift from
Novo Nordisk (Norditropin Simplexx; Novo Nordisk, Denmark).
Adult 17–21-wk-old PICK1-deficient mice were treated with GH
(250 mg/20 g mouse) once daily for 3 wk. The mice were scanned
in an echo MRI every week, and after the two first weeks of
treatment, the mice were fasted for 16 h and challenged with an
OGTT, and additionally 4 d later, the mice were exposed to an
ITT after 2 h fasting. One experimental day and also 2 d before
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final termination by cervical dislocation, no GH was administrat-
ed. After termination the liver was dissected and frozen in liquid
nitrogen in small pieces.
Glucose Metabolism Measurements
OGTTs were carried out in 10–13-wk-old mice. The animals
were fasted overnight for 16–18 h with free access to water.
Glucose (1.5 g/kg body weight) was orally administered [43].
Blood glucose levels were monitored in the blood samples obtained
from tail punctures using a handheld glucometer (Ascensia
Contour Glucometer, Bayer) before and after glucose administra-
tion. At time points 0 and 15 min, blood was collected from the
orbital sinus for measuring plasma insulin levels using Sensitive
Insulin RIA KIT (Linco Research). Mice at age 27–29 wk were
used for ITT. Food was removed 2 h before the test. Mice were
i.p. injected with insulin at a dose of 0.75 U/kg body weight
(Actrapid, Novo Nordisk, Denmark) [61]. Blood glucose levels
were monitored as in the OGTT.
Quantitative Real-Time PCR
Relative mRNA levels were measured by quantitative real-time
PCR (RT-QPCR) using the Mx3000P from Stratagene and SYBR
Premix Ex TaqTM (Takara) [62]. The relative levels of genes,
from different samples, were compared by the DDCt method,
using the tyrosine 3-monooxygenase/tryptophan 5-monooxygen-
ase activation protein, zeta polypeptide (YWHAZ), or hypoxan-
thine phosphoribosyltransferase 1 (HPRT1) as reference gene. In
flies in which the internal control was Rp49, a gene encoding a
ribosomal subunit was used. Before calculating the DDCT value,
primer efficiency was validated by standard curve measurements,
and primers with more than 95% efficiency was used. A calibrator
sample was included in each assay for normalization between runs.
RNA was extracted with RNeasy Lipid Tissue Mini kit (Qiagen),
and cDNA was synthesized by reverse transcription using the
ImProm-IITM Reverse Transcriptase (Promega).
For RT-PCR in Drosophila, total RNA was purified from fly
heads with Nucleospin RNA-II columns (Macherey-Nagel, Du¨ren,
Germany). For RT-PCR on liver samples, one steel bead together
with 1 ml of QIAzol Lysis Reagent were added and mixed with a
TissueRuptor. First strand synthesis was performed using Super-
script III reverse transcriptase (Invitrogen). As internal control, the
gene Rp49 encoding a ribosomal subunit was used. RT-PCR was
performed on a Mx3000P (Stratagene) using Platinum SYBR
Green qPCR Supermix with ROX added as reference dye
(Invitrogen).
Immunohistochemistry
For immunostaining of Drosophila adult brain tissue, brains were
dissected from female flies 24–48 h posteclosionin HL3 medium,
fixed in PBS with 4% formaldehyde for 30 min on ice, and
transferred to PBX (PBS+0,3% Triton-X100). After 6610 min
washes in PBX at RT, samples were blocked in PBX with 5%
Normal Goat Serum for 30 min at RT and incubated with
primary antibody overnight at 4uC. This was followed by 8610-
min washes in PBX at RT and secondary antibody incubation in
PBX with 5% normal goat serum for 2 h at RT. Finally, the
samples were washed in 8610 min in PBX and 265 min in
deionized water at RT and mounted in ProLong Gold antifade
reagent (Invitrogen). Polyclonal rabbit anti-Drosophila PICK1
(SPY740, described in [20]) and polyclonal rabbit anti-Drosophila
golgin-97 [63] were used in a concentration of 1:300, polyclonal
rat anti-dILP2 [64] was used in a concentration of 1:800, and
monoclonal rat anti-HA antibody (3F10, Roche) was used in a
concentration of 200 pg/ml. As secondary antibodies, we used
Alexa Fluor 488 goat anti-rabbit IgG (for PICK1 and golgin 97),
Alexa Fluor 546 goat anti-rat IgG (for ICA69-HA), and Alexa
Fluor 647 goat anti-rat IgG (for PICK1-HA and dILP2). For
detection of dILP2, flies were kept on standard medium
complemented with dried yeast.
For mouse immunohistochemistry, adult mice were sacrificed
by decapitation, brains were rapidly removed, and pituitaries from
PICK1 WT (n=7) and PICK1-deficient mice (n=7) were
dissected out. Pituitaries were then rapidly frozen and kept at
280uC until further processing. Subsequently, pituitary sections
were cut on a cryostat (15 mm) and mounted on superslide glasses
(SuperFrost Plus, Menzel-Gla¨ser, Braunschweig, Germany).
Mounted pituitary sections were fixated in 4% paraformaldehyde
(PFA) for 20 min and then rinsed in phosphate buffered saline
(PBS) three times followed by preincubation for 30 min with 5%
(v/v) goat serum in PBS containing 0.1% (v/v) Triton X-100. For
PICK1 colocalization with hormones, sections were then incubat-
ed with mouse monoclonal PICK1 antibody (2G10, 1:500), rabbit
polyclonal GH antibody (1:500, DAKO Cytomation A/S, Den-
mark), rabbit polyclonal ACTH antibody (1:250, Abcam, UK), or
rabbit prolactin antibody (1:200, Abcam, UK). For PICK1
colocalization, studies with ICA69 mouse monoclonal PICK1
antibody (2G10, 1:500) and rabbit polyclonal islet cell autoantigen
(ICA-69) (1:100, source, a kind gift from Massimo Pietropaolo,
University of Michigan, Ann Arbor, MI, USA) [22] were
incubated at 4uC overnight. On the second day, sections were
rinsed in washing buffer (0.25% bovine serum albumin (BSA),
0.1% Triton X-100 in PBS) and incubated with secondary
antibodies Alexa Fluor 488 goat anti-mouse IgG (for PICK1) and
Alexa Fluor 568 goat anti-rabbit IgG (for ICA69 or GH) for 1 h
(Molecular Probes, USA). This was followed by additional rinsing
in washing buffer and PBS. Sections were finally coverslipped
using Prolong Gold antifade reagent (Molecular Probes, Invitro-
gen).
DNA Constructs
The plasmid encoding PICK1 N-terminally tagged with GFP
was a kind gift from Dr. Kumlesh Dev (Trinity College, Dublin,
Ireland). The constructs encoding YFP-PICK1, YFP-PICK1 BAR
(D101), and YFP-PICK1 BAR (D101) 3KE in peYFP C1
(Clonetech, USA) were described previously [18]. The YFP-
PICK1 BAR (D101) mutant V121E-L125E was generated by
Quick-change (Stratagene) on YFP-PICK1 BAR and subsequently
subcloned back into the peYFP C1 vector. The mycPICK1
construct in pCMV was a kind gift from Dr. Harvey T. McMahon
(MRC Cambridge, UK) and was described previously [18]. GST
PICK1 BAR (D101) in the pET41 vector was subcloned from
previously described GST-PICK1 [65] and reintroduced in
pET41 using MfeI and AvrII. The GST-PICK1 BAR (D101)
mutant V121E-L125E was generated by Quick-change (Strata-
gene) on GST-PICK1 BAR and subsequently subcloned back into
the pET41 vector [18]. HA-ICA69 in pcDNA5/FRT/TO was
subcloned by PCR from a cDNA of the human sequence
purchased from OriGene, introducing an N-terminal hemaglutti-
nin (HA) tag. Cerulean-GalT was generated by Jennifer
Lippincott-Schwartz and was purchased from Addgene (MA,
USA). CgA-GFP [66] was kindly supplied by Dr. Laurent
Taupenot. All constructs were verified by sequencing (MWG
Operon, Germany).
Cell Culture and Generation of Stable Cell Lines
GH1 cells were maintained in DMEM 1965 with Glutamax (L-
alanyl-L-glutamine) containing 5% fetal calf serum and Pen/Strep
at 37uC in a humidified 10% CO2 atmosphere [31]. ATT20 cells
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were maintained in DMEM 1965 supplied with 10% fetal calf
serum and Pen/Strep at 37uC in a humidified 5% CO2
atmosphere. COS-7 cells were maintained in DMEM 1965 with
Glutamax (L-alanyl-L-glutamine) containing 10% fetal calf serum
and 0.01 mg/mL gentamicin (Invitrogen) at 37uC in a humidified
5% CO2 atmosphere. Cells were transfected using Lipofectamine
2000 (Invitrogen) and were used for experiments after 2 d. To
generate a cell line with stable tetracycline-inducible expression of
HA-ICA69, we used the FlpIn T-REx system and the Flp-In T-
REx 293 cell line (Invitrogen). Cells (90% confluent) were
transfected using Lipofectamine 2000 (Invitrogen) with a total of
3 mg of DNA in a 1:9 ratio of the pcDNA5/FRT/TO with the
HA-ICA69 insert, and pOG selection was induced using 15 mg/ml
blasticidin and 150 mg/ml hygromycin. The stable HA-ICA69
expressing cells were maintained in DMEM 1965 containing 10%
fetal calf serum at 37uC, and cells were selected using 15 mg/ml
blasticidin and 100 mg/ml hygromycin (both from Invitrogen).
Immunocytochemistry
For immunocytochemistry, cells were trypsinized and seeded on
polyornithine-coated coverslips in six-well plates (150,000–
300,000 cells/well depending on cell type). COS7 and Flp-In T-
REx cells were transfected with Lipofectamine 2000 (Invitrogen)
for 16 h in Optimem (Invitrogen) using a total of 1 mg DNA/well.
In general, we transfected ,80% of the COS7 cells and ,40% of
the Flp-In T-REx cells. For immunostaining, cells were washed in
PBS (phosphate buffered saline, pH 7.4), fixed in 4% paraformal-
dehyde for 20 min, washed in PBS, and permeabilized by
incubation for 30 min in PBS containing 5% goat serum and
0.2% saponin or 0.1% TX100 for COS7 cells. Primary antibodies
including chicken anti-PICK1 (1:500) (Novus Biologicals), rabbit
ICA69 (1:500), rabbit GH (1:400) (DAKO Cytomation A/S,
Denmark), mouse 58K (Abcam, UK), rabbit TGN38 (Sigma-
Aldrich, USA), rabbit Giantin (Biosite, USA), rabbit GM130
(Sigma-Aldrich, USA), rabbit Ergic53 (Sigma-Aldrich, USA),
mouse Syntaxin6 (3D10 Abcam, UK), mouse HA11 (Covance,
USA), or rabbit LAMP1 (Abcam, UK) were added for 1 h
followed by three washes and incubation with Alexa Fluor 488
goat anti-mouse IgG or Alexa Fluor 488 goat anti-rabbit IgG,
together with Alexa Fluor 568 goat anti-chicken IgG (1:500)
(Molecular Probes, USA) for 30 min prior to mounting in Prolong
Gold antifade reagent (Molecular Probes, USA). For labeling of
the endocytic pathway (early and recycling endosomes), cells were
fed Alexa Fluor 488–conjugated transferrin (Molecular Probes,
USA) at 37uC for 1 h prior to PICK1 immunostaining as
described above.
RNAi-Mediated Knockdown in GH1 and ATT20 Cells
For GH1 and ATT20 RNAi studies, cells were used the
BLOCK-iT Pol II miR RNAi Expression Vector Kit (Invitrogen,
USA). Cells were transfected using Lipofectamine 2000 (Invitro-
gen, USA) with the pcDNA 6.2-GW vector, which has co-cistronic
expression of miRNA with EmGFP (Emerald Green Fluorescent
Protein), which permits visual selection of cells expressing the pre-
miRNA. We used two pre-designed BLOCK-iT miR RNAi Select
oligos against rat PICK1 and rat ICA69 (both PICK1 shRNAs but
only one ICA69 shRNA worked in the mouse ATT20 cell line) as
well as the negative control supplied. Two days after transfection,
immunocytochemistry was performed as described above using
mouse PICK1 2G10 (1:500) (previously described) [20] together
with either rabbit GH 1:400 (DAKO Cytomation A/S, Denmark)
or rabbit ICA69 1:500. To allow for parallel visualization of
EmGFP, the PICK1 antibody was visualized using Alexa Fluor
647 goat anti-mouse IgG and rabbit antibodies were visualized
using Alexa Fluor 568 goat anti-rabbit IgG. For ATT20 cells, we
used Alexa Fluor 568 goat anti-mouse IgG, and rabbit antibodies
were visualized using Alexa Fluor 647 goat anti-rabbit IgG.
Confocal Microscopy and Image Analysis
Visualization of mouse pituitary sections and cell lines was
performed with a Zeiss LSM 510 inverted confocal laser-scanning
microscope using an oil immersion numerical aperture 1.4 636
objective (Zeiss, Jena, Germany). The Alexa Fluor 488 dye, GFP,
YFP, and EmGFP were excited with the 488 nm laser line from an
argon–krypton laser, and the emitted light was detected using a
505–550 nm band pass filter. The Alexa Fluor 568 dye was
excited at 543 nm with a helium–neon laser, and the emitted light
was detected using a 560–615 nm band pass filter. For three color
experiments, the Alexa Fluor 647 was excited at 633 nm with
another helium-neon laser, and emitted light was detected using a
650 long pass filter. Channels were imaged separately. Resulting
images were combined using IMAGEJ software (Rasband W. S.,
ImageJ, U.S. National Institutes of Health, Bethesda, MD, USA).
Drosophila specimens were visualized using a Leica TCS SP2
confocal microscope (206and 636water immersion objectives), a
Zeiss 510 upright confocal microscope with a C-Apochromat
636/1.2 W Corr water immersion objective (Figure 7A and
Figure S3G), or a Zeiss 710 upright confocal microscope using a
Plan-Apochromat 636/1.40 Oil DIC M27 oil immersion
objective (Figure S3H). The Alexa Fluor 488 dye was excited
with a 488 nm argon laser line, the Alexa Fluor 546 dye was
excited with a 543 nm helium-neon laser, and the Alexa Fluor 647
dye was excited with a 633 nm helium-neon laser.
For quantification of PICK1, GH, and ICA69 immunoreactiv-
ity in GH1 and ATT20 cells, EmGFP expressing cells were
outlined in the green channel, yielding separate regions of interest
(ROIs), and the non-EmGFP expressing cells were grouped as a
single ROI. Background levels were subsequently adjusted
separately for each picture in the red and the blue channel before
the total intensities of the ROIs were measured. Finally, the
cumulated intensity of each EmGFP expressing ROI was
compared to the average intensity of cells in the Non-EmGFP
ROI within the same cell cluster. All image analysis was performed
using IMAGEJ software (RasbandW. S., ImageJ, U.S. National
Institutes of Health, Bethesda, MD, USA). Finally, the data were
transferred to GraphPad Prism Statistical Software Version 4.0 for
presentation and statistical analysis. The data did not show normal
distribution according to the Shapiro-Wilk normality test. Hence,
the Mann–Whitney Rank Sum Test was used for statistical
analysis of data.
Quantification of co-localization was done using Van Steensel’s
cross-correlation function, which reports the Pearson cross-
correlation as a function of the relative movement of the two
channels with respect to each other. This was done using the
JaCoP Plug-in for ImageJ [33] with the x-shift set to 20 pixels. Co-
localization was quantified for 10–20 cells from three independent
experiments. According to the cross-correlation function, com-
pletely co-localizing structures will show a cross-correlation
function, peaking sharply at DX=0 with a maximum value close
to one, and mutually exclusive structures will tend to show no peak
or even a dip at DX=0. Partial co-localization will give rise to
reduced maximum cross-correlation, as will noise. For adjacent
and partially overlapping structures, the cross-correlation peak will
become broader and/or shift away from a maximum at DX=0
[33]. Quantification of punctate to total CgA-GFP signal in COS7
cells was done in ImageJ by thresholding the images and making a
ROI excluding the coherent cluster of CgA-GFP containing the
rest of the cell. The cumulated intensity outside the cluster was
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divided by the cumulated intensity for the entire cell. Finally, the
data were transferred to GraphPad Prism Statistical Software
Version 4.0 for presentation and statistical analysis.
Time Lapse Confocal Microscopy
For time lapse confocal microscopy, GH1 cells were seeded in
Labtek II eight-well chamber 24 h before co-transfection of YFP-
PICK1, YFP-PICK1 BAR, or YFP-PICK1 BAR 3KE in the
peYFP C1 vector (Clonetech, USA) with Cerulean-GalT in a 1:3
ratio. Imaging was performed on the following day and was done
at ,35uC. Cerulean-GalT was exited with the 458 nm laser line
and YFP with the 514 nm laser line from the argon laser and the
emitted light directed through a 515 nm beam splitter and
detected through 475–525 nm band pass and a 530 nm LP filter,
respectively. We observed minimal cross-talk between the
channels using these settings. We imaged an area of
,24624 mM (2606260 pixels) and switched between the two
channels after every scanned line. Time lapses contained 100
frames with ,3 s time resolution. Maximal intensity projections
were carried out using ImageJ, and the presented images, time
lapses, and supplemental movies were passed through the mean
filter (radius 2 pixels) in ImageJ.
Transmission Electron Microscopy
WT and PICK12/2 mice were fixed by vascular perfusion
through the left ventricle of the heart with 2% glutaraldehyde in
0.05 M sodium phosphate buffer (pH 7.2) for 2 min. Following
fixation, the pituitary was dissected from the brain, and the
samples were rinsed three times in 0.15 M sodium cacodylate
buffer (pH 7.2) and subsequently postfixed in 1% OsO4 in
0.12 M sodium cacodylate buffer (pH 7.2) for 2 h. The
specimens were dehydrated in graded series of ethanol,
transferred to propylene oxide, and embedded in Epon
according to standard procedures. Ultrathin sections were cut
with a Reichert-Jung Ultracut E microtome and collected on
200 mesh copper grids with Formvar supporting membranes.
The sections were stained with uranyl acetate and lead citrate
and examined with a Philips CM 100 transmission electron
microscope operated at an accelerating voltage of 80 kV and
equipped with a SIS MegaView II camera. Digital images were
recorded with the analySIS software package.
Giant Membrane Vesicle Deformation
Full-length PICK1 and PICK1 truncated at position 101
(PICK1 D101) [18] were expressed as GST (gluthathion-S-
transferase) fusion proteins from pPET41 in E. coli BL21 DE3
pLysS cells and purified as described [49]. Cysteines in GST were
fluorescently labeled with 100 mM Alexa 488 maleimide (Invitro-
gen) at 4uC for 1.5 h, washed three times with 10 ml buffer
B+1 mM DTT, and eluted by addition of 10 mM glutathione.
Purity and integrity of the protein were inspected by SDS–PAGE,
and labeling efficiency was determined by fluorescence spectros-
copy. Giant membrane vesicles were prepared from a lipid
mixture containing 40% Phosphatidylcholine (DOPC), 32%
Phosphatidylethanolamine (DOPE), 10% Phosphatidylserine
(DOPS), 10% Cholesterol, 5% Phosphatidylinositol-4,5-bispho-
sphate (PtdIns(4,5)P2), 0.5% DOPE-biotin, and 0.5% DOPE-
Atto633 (Attotec). All lipids were from Avanti polar lipids. The
lipids were mixed from chloroform stocks and a thin lipid film was
formed in a teflon cup upon solvent evaporation. The giant
vesicles were generated by standard rehydration in TBS buffer
(10 mM Tris, pH 7.4, and 95 mM NaCl) overnight at 37uC. Glass
surfaces were passivated with a BSA:BSA-Biotin mixture and
subsequently coated with streptavidin onto which the biotinylated
vesicles tethered, as described previously [67]. The immobilized
giant liposomes were incubated at room temperature with
0.8 mM–purified and Alexa Fluor 488–labeled GST-PICK1
D101 (BAR) or a mutant GST-PICK1 D101 (control) with
impaired membrane-binding capacity (Val121Glu, Leu125Glu)
(Madsen, Bhatia, Stamou, and Gether, unpublished observation).
Subsequent microscopy was performed on a Leica TCS SP5
confocal fluorescence microscope, with AOBS/AOTF system
allowing tunable wavelength detection intervals. The objective
used was an oil immersion HCX PL APO with 1006 magnifi-
cation and numerical aperture 1.4. Vesicles and tubes containing
DOPE-Atto633 dye were excited at 633 nm, detecting emission
from 640 nm to 790 nm. The microscope was kept at a constant
temperature of 22uC.
Co-Immunoprecipitations
For co-immunoprecipitation of PICK1 and ICA69 from flies,
heads were collected from female flies expressing Drosophila
ICA69-HA and PICK1A under the control of the elav-GAL4
driver (elav-GAL4/+; UAS-ICA69-HA/UAS-PICK1A). The heads
were homogenized on ice in modified RIPA buffer (20 mM Tris-
HCl, 7.5 pH, 150 mM NaCl, 10 mMMgCl2, 0.5% NP-40, 1 mM
PMSF, 1 Complete Protease Inhibitor Cocktail tablet (Roche) per
25 ml buffer). The resulting homogenate was passed through a 25
gauge needle seven times and centrifuged at 20,8006 g at 4uC
until the supernatant was clear. The concentration of the
supernatant was subsequently adjusted to 1 mg/ml protein. One
ml of lysate per binding reaction was cleared with 15 ml Protein-
G Agarose beads (Roche) for 1 h. Beads were removed by
centrifugation at 2,7006 g for 5 min at 4uC, and 4 mg/ml rat
anti-HA (3F10, Roche) was added to the supernatant. Immune
complexes were allowed to form for 12 h before the addition of
15 ml Protein-G Agarose beads, followed by an additional 4 h of
incubation. All incubations were done at 4uC under gentle
agitation. Beads were then pelleted by centrifugation at 2,7006
g for 5 min at 4uC and washed 4 times with 1 ml modified RIPA
buffer. The bound material was eluted by boiling for 5 min in
loading buffer before analysis by SDS-PAGE and immunoblot-
ting with mouse anti-HA (16B12, Covance) to detect immuno-
precipitated ICA69-HA and rabbit anti-Drosophila PICK1
(SPY740) [9] to detect coimmunoprecipitated endogenous
PICK1, respectively.
For co-immunoprecipitation in GH1 cells, cells were grown to
confluence and lysed for 30 min at 4uC in lysis buffer (PBS+1%
Triton X-100) supplemented with Complete protease Inhibitor
Cocktail tablet (Roche, Mannheim, Germany). Protein G agarose
beads (Roche, Mannheim, Germany) were preincubated 1 h with
monoclonal 2G10 mouse anti-PICK1 antibody, and the cell lysate
was cleared by spinning 30 min at 16,000 rpm at 4uC in a tabletop
centrifuge. The resulting supernatant was transferred to the
antibody-agarose bead mix, and the sample was incubated for 1 h
at 4uC under constant rotation. Lysates incubated with agarose
beads without antibody were included as control. After incubation,
samples were washed once in lysis buffer, twice in PBS with 1%
Triton X-100 and 500 mM NaCl, and three times in PBS. After
washing, protein was eluted from the beads by adding SDS-PAGE
loading buffer. Samples were analyzed by SDS-PAGE and
immunoblotted with polyclonal guinea pig anti-PICK1 and rabbit
anti-ICA69 to detect immunoprecipitated PICK1 and coimmu-
noprecipitated ICA69, respectively.
HSD Model in Drosophila
To establish the HSD model [38–40], WT flies were allowed to
deposit eggs on an apple juice plate for 6 h. On the following day,
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first instar larvae hatched from the eggs were transferred to vials
either containing food with a standard amount of sucrose or five
times that amount (HSD). The food contained (g/L): agar, 10;
yeast, 34; corn meal, 82.5, sucrose, 60 (for standard food) or
300 (for HSD) and also included mold inhibitors (ml/L):
Nipagin in ethanol, 15; propionic acid, 2. Quantitative RT-
PCR was performed according to methods described above on
mRNA isolated from pooled heads of fully developed adult
female flies reared on standard food (n= 9 samples), or on HSD
(n= 7).
Statistical Analysis
Statistical analysis was performed using GraphPad Prism
Statistical Software Version 4.0. Two-tailed Student’s t test was
used for comparison between two groups. One-way ANOVA
followed by Bonferroni post hoc tests was used to analyze body
weight and composition in mice. Two-way repeated measures
ANOVA followed by Bonferroni post hoc tests were used for the
analysis of data of ghrelin-induced GH secretion, OGTT, insulin
level during OGTT, and ITT. All data are presented as mean 6
SE. We considered p,0.05 significant. Other statistical procedures
are described in the relevant sections.
Supporting Information
Figure S1 Body composition of PICK1-deficient mice and
measurement in PICK1-deficient mice of water intake, food
intake, energy expenditure, and respiratory exchange rate by
indirect calorimetry. (A and B) Lean mass and fat mass were
determined in live, unanesthetized mice at 15–17 wk of age by
quantitative magnetic resonance scanning. Data are given as total
amount of fat and lean body mass and presented as means 6 SE
(n=7–10). ***p,0.001, compared to WT mice; ##p,0.01,
compared to KO mice. (C to H) Measurement of water intake,
food intake, energy expenditure, and respiratory exchange rate
was performed in cages optimized for indirect calorimetry with
individual scales for food and water. Indirect calorimetry in
PICK1-deficient and WT mice were done at the age of 11–13 wk
with mice placed in calorimetry cages for 8 d. (C) Average 12 h
water intake and (D) food intake in the light and dark period for
WT (+/+)(white column) and GPR39-deficient (2/2) mice (black
column). (E) Average 12 h oxygen consumption rate (VO2: ml/h/
kg fat free mass) and (F) respiratory exchange rate in the light and
dark period for WT (+/+)(white column) and GPR39-deficient
(2/2) mice (black column). (G) Oxygen consumption rate (VO2:
ml/h/kg fat free mass) and (H) respiratory exchange rate in the
dark and light period for WT (+/+) (black line) and PICK1-
deficient (2/2) (grey line). Data were analyzed by one-way
ANOVA followed by Bonferroni post hoc test. Data are shown as
means 6 SE, n=7.
(EPS)
Figure S2 Protein level, total protein of ACTH, prolactin (in
ng/mg), and TSH (in uU/ug) measured by ELISA in pituitary
extracts taken from 34-wk-old WT (+/+) and PICK1-deficient (2/
2) mice. Data are expressed as means 6 SE (n=4). *p,0.05
compared to WT mice.
(EPS)
Figure S3 Immunohistochemical localization of PICK1 to
ACTH and prolactin-producing cells in mice pituitary. Confocal
images of 15 mm slices from the pituitary of WT (+/+) mice,
immunostained for PICK1 (green) and ACTH (red) (top), and
PICK1 (green) and prolactin (red) (bottom). Insets show cells
expressing both PICK1 and ACTH (top) or prolactin (bottom).
Scale bar, 10 mm. Pictures are representative of stainings of three
pituitaries.
(EPS)
Figure S4 shRNA-mediated knockdown of PICK1 reduces
ACTH immunosignal in ATT20 cells. (A) PICK1 is expressed
in ACTH-producing ATT20 cells, and PICK1 knockdown
reduces apparent ACTH content. Confocal images of ATT20
cells immunostained for PICK1 (red) and ACTH (red). Cells
transfected with shRNA against PICK1 are identified by obligate
co-expression of green fluorescent protein (EmGFP) (green) and
are outlined in white. Scale bar, 10 mm. (B and C) Quantification
of PICK1 immunosignal (B) and ACTH immunosignal (C) in
GFP-positive cells transfected with either of two different shRNAs
against PICK1 (52 and 53). Data are percentage of signal in
surrounding nontransfected cells (mean 6 SE) for control shRNA
(shControl) (n=25), shPICK1 (52) (n=46), and shPICK1 (53)
(n=24). ***p,0.001, **p,0.01, compared to shControl, Mann–
Whitney rank sum test.
(EPS)
Figure S5 Co-localization of PICK1 with vesicular markers in
GH1 cells. Confocal images of GH1 cells immunostained for
PICK1 and indicated endocytic pathway markers. Left panels
show signal from immunolabeled PICK1 (Alexa Fluor 568
signal), middle panels signal from immunolabeled endocytic
marker (Alexa Fluor 488 signal), and right panels overlay of the
two channels. (A) Transferrin (early and recycling endosomes).
(B) LAMP1 (lysozomes). (C) Ergic 53. Insets highlight lack of co-
locolization of PICK1 with transferrin and LAMP1 and partial
colocalization with Ergic 53. Pictures are representative of three
to six independent experiments. (D) Quantification of the
PICK1 colocalization with tranferrin, LAMP1, and Ergic 53
using Van Steensel’s cross-correlation function, which report the
Pearson cross-correlation as a function of the relative movement
of the two channels with respect to each other. Neither
transferrin nor LAMP1 co-localize with PICK1, whereas the
sharp peak close to Dx = 0 indicates partial but specific co-
localization for Ergic 53. Co-localization was quantified for 10–
20 cells from three independent experiments, and data are
means 6 SE.
(EPS)
Figure S6 Confocal images of GH1 cells immunostained for
PICK1 and indicated markers and of HA-tagged PICK1A and
indicated markers in the adult Drosophilia brain. (A and B) Confocal
laser scanning micrographs of GH1 cells immunostained for
PICK1 and indicated Golgi markers. Left panels show signal from
immunolabeled PICK1 (Alexa Fluor 568 signal), middle panels
signal from immunolabeled Golgi marker (Alexa Fluor 488 signal),
and right panels overlay of the two channels. (A) GM130 (cis-
Golgi) and (B) 58K (entire Golgi). Insets highlight adjacent
localization rather than co-localization of PICK1 with Golgi
markers. Pictures are representative of three to six independent
experiments. (C) Immunostainings for HA-tagged PICK1A (red)
and golgin 97 (green) in a single cell in lateral protocerebrum of
the adult Drosophilia brain. PICK1A-HA was expressed using the
c929-GAL4 driver (c929-GAL4 PICK1/UAS-PICK1A-HA PICK2).
PICK1A-HA is seen as clusters that are primarily next to the
staining for the trans-Golgi marker, golgin-97, rather directly
overlapping. (D) Immunostainings for endogenous PICK1 (green)
and dILP2 (red) in median neurosecretory cells of the pars
intercerebralis in the adult Drosophila brain. The PICK1 staining
shows partial overlap with DILP2 staining but mostly clusters
around zones of high dILP2 immunoreactivity. Scale bars are
5 mm in panels and 1 mm in insets, respectively. (E and F) Punctate
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co-localization of PICK1, syntaxin 6, and GH in GH1 cells. (E)
Confocal laser scanning micrographs of GH1 cells with the first
image (from left) showing signal from immunolabeled PICK1
(Alexa Fluor 568 signal, red), second image signal from syntaxin 6
(Alexa Fluor 488 signal, green), third image from GH (Alexa Fluor
647 signal, blue), and fourth panel overlay of the three channels.
The PICK1 and syntaxin 6 signals are oversaturated in the
perinuclear region to enable visualization of the weaker punctuate
expression together with the exclusively punctate GH signal (blue).
(F) Representative intensity profiles from (E) indicated by i, ii, and
iii through numerous vesicles demonstrating several incidents of
co-localization of the immunosignals from PICK1 (red), syntaxin6
(green), and GH (blue).
(EPS)
Figure S7 Punctate localization adjacent to the Golgi compart-
ment of GFP-PICK1 BAR in GH1 cells. PICK1 BAR tagged N-
terminally with GFP (GFP-PICK1 BAR) (left) or the mutants
GFP-PICK1 BAR V121E-L125E (middle) and GFP-PICK1 BAR
3KE (right) (all shown in yellow) were expressed in GH1 cells
together with the Golgi marker GalT, b1,4-galactosyltransferase
fused to cerulean fluorescent protein (GalT-cerulean) (shown in
blue). Confocal imaging showed a punctate localization of YFP-
PICK1 BAR with many punctae lining the GalT-cerulean
visualized Golgi compartment. PICK1 BAR V121E-L125E
showed a similar punctate localization, whereas GFP-PICK1
BAR 3KE localized diffusely in the cytoplasm. The erased white
areas correspond to the nuclei of the cells.
(EPS)
Figure S8 ShRNA-mediated knockdown of PICK1 reduced
ICA69 expression in ATT20 cells and vice versa. (A) Confocal
images of ATT20 cells immunostained for PICK1 and ICA69.
Cells were transfected with shRNA against PICK1 and identified
by obligate co-expression of EmGFP (cells lined in white). First
image (from left) shows EmGFP signal, second image signal from
PICK1 (Alexa Fluor 568 signal), third image signal from
immunolabeled ICA69 (Alexa Fluor 647 signal), and fourth panel
image overlay of the three channels. Pictures are representative of
multiple cells imaged on three independent occasions. Scale bar,
10 mm. (B) Quantification of PICK1 expression and (C) ICA69
expression in GFP-positive cells transfected with either of two
different shRNAs (52 and 53) against PICK1. Data are presented
as percent of expression in surrounding nontransfected cells
(means 6 SE) for control shRNA (shControl) (n=36), shICA69
(24) (n=55), and shPICK1 (25) (n=24). (D) Confocal images of
ATT20 cells immunostained for PICK1 and ICA69. Cells were
transfected with shRNA against ICA69 and identified by obligate
co-expression of EmGFP (cells lined in white). First image (from
left) shows EmGFP signal, second image signal from PICK1
(Alexa Fluor 568 signal), third image signal from immunolabeled
ICA69 (Alexa Fluor 647 signal), and fourth panel image overlay of
the three channels. Pictures are representative of multiple cells
imaged on three independent occasions. Scale bar, 10 mm. (E)
Quantification of ICA69 expression and (F) PICK1 expression in
GFP positive cells transfected with either of two different shRNAs
(24 and 25) against ICA69 (sh25 not quantified for PICK1 since it
does not knock down ICA69 in ATT20 cells). Data are presented
as percent of expression in surrounding nontransfected cells
(means 6 SE) for control shRNA (shControl) (n=36), shICA69
(24) (n=26), and shPICK1 (25) (n=29). *** indicate that medians
are significantly different from the control with p,0.001 as
determined by Mann–Whitney rank sum test (data do not show
normal distribution).
(EPS)
Figure S9 ShRNA-mediated knockdown of ICA69 reduces
PICK1 expression in GH1 and ATT20 cells. (A) Confocal laser
scanning micrographs of GH1 cells immunostained for ICA69 and
PICK1. Cells were transfected with shRNA against ICA69 and
identified by obligate coexpression of EmGFP (cells lined in white).
First image (from left) shows signal from immunolabeled ICA69
(Alexa Fluor 568 signal), second image signal from PICK1 (Alexa
Fluor 647 signal), third image EmGFP signal, and fourth panel
image overlay of the three channels. Pictures are representative of
multiple cells imaged on three independent occasions. Scale bar,
10 mm. (B) Quantification of ICA69 expression and (C) PICK1
expression in GFP-positive cells transfected with either of two
different shRNAs (24 and 25) against ICA69. Data are presented
as percent of expression in surrounding nontransfected cells
(means 6 SE) for control shRNA (shControl) (n=49), shICA69
(24) (n=72), and shPICK1 (25) (n=65). *** indicate that medians
are significantly different from the control with p,0.001 as
determined by Mann–Whitney rank sum test (data do not show
normal distribution).
(EPS)
Figure S10 PICK1 stabilizes HA-ICA69 expression in Flp-In T-
Rex 293 cells. Flp-In T-Rex 293 cells stably expressing HA-tagged
ICA69 (HA-ICA69) in a tetracycline-dependent manner (Flp-In
T-Rex 293 HA-ICA69 cells) were transfected with pcDNA3 or
mycPICK1 before induction of the cells with tetracycline for 24 h.
Cell lysates were subsequently analyzed by Western blotting. (Left)
The gel shows three independent experiments with HA-ICA69 on
top and Actin at bottom as loading control. (Right) Quantification
of the HA-ICA69 signal normalized to Actin. Data are means 6
SE, ***p,0.001 in Student’s t test.
(EPS)
Movie S1 Time lapse series of YFP-PICK1 BAR and GalT-
Cerulean showing highly mobile punctate structures of YFP-
PICK1 BAR concentrated at the lining of the Golgi. In addition,
several punctuate structures appear and disappear during the time
lapse series. The movie is 100 frames with 3 s intervals (total time
,5 min). The size is ,24624 mm.
(MOV)
Movie S2 Time lapse series of YFP-PICK1 BAR V121E-L125E
and GalT-Cerulean showing mainly stable punctate structures of
YFP-PICK1 BAR V121E-L125E both at the lining of the Golgi
and elsewhere in the cell. Few punctuate structures appear and
disappear during the time lapse series. The movie is 100 frames
with 3 s intervals (total time ,5 min). The size is ,24624 mm.
(MOV)
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